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Krüppel-associated box-containing zinc finger proteins (KRAB-ZNFs) represent a large 
family of transcription regulators in tetrapods. Typically, KRAB-ZNF proteins consist of an 
amino-terminal protein interaction domain, designated KRAB, and a carboxy-terminal tandem 
array of DNA-binding C2H2 zinc finger motifs as initially determined in KOX1/ZNF10. In 
the canonical model of function, zinc finger motifs specifically bind to genomic target sites 
while the KRAB domain interacts with TRIM28 that in turn recruits chromatin-modifying 
protein complexes including enzymes such as histone methyltransferase SETDB1 and histone 
deacetylase HDAC1. The KRAB/TRIM28-mediated interaction initiates a local spreading of 
repressive chromatin structures promoting epigenetic silencing. A subset of KRAB-ZNFs has 
been described to contain N-terminally an additional conserved protein domain designated 
“domain of unknown function 3669” (DUF3669).  The human genome encodes six human 
KRAB-ZNF proteins with DUF3669 at their N-termini. One of them is ZNF746/PARIS, 
which was involved in Parkinson's disease, and ZNF777, which is known as one of the oldest 
evolutionary family members of the KRAB-ZNF. The aim of this study was to evaluate 
transcriptional repression functions of DUF3669-KRAB amino-terminal domain arrays in 
ZNF746 and ZNF777 in comparison to the canonical KRAB/TRIM28 pathway. Further, the 
aim of this study was to answer the question as to whether DUF3669 can mediate protein 
oligomerization.  
The ZNF746 major isoform (ZNF746a) is characterized by a 15-aa truncated KRAB-A 
subdomain. The existence of a second isoform (ZNF746b) containing a non-truncated KRAB 
domain was proven by RT-PCR. Heterologous reporter assays showed that the most efficient 
downregulation of the reporter gene was achieved by the entire amino-terminal array of a 
ZNF746 isoform corresponding to DUF3669, KRAB domain variant, and further sequence 
encoded by exons 5 and 6. Yet, these repression factors were still moderate as compared to 
the potent KRAB domain of ZNF10. Interestingly, the isolated DUF3669 domain of ZNF746 
and ZNF777 showed intrinsic weak transcriptional repression activities. Most importantly, the 
DUF3669 region was sufficient to confer direct physical interaction among the members of 
the subfamily in oligomers, which might explain the contribution of DUF3669 to the 
repression activity. The ability of DUF3669 to modulate the repression activities in 
DUF3669-KRAB segments of ZNF746 and ZNF777 was found to be context-dependent since 
the heterologous transfer of DUF3669 to the potent KRAB domain of ZNF10 did not augment 




protein segment encoded by exons 5 and 6 to repression was ascribed to a potential 
SUMOylation event at K189 (in ZNF746a). Neither ZNF746a nor ZNF777 protein segments 
stably associated with TRIM28 within cells. Conversely, ZNF746b segments that contain the 
non-truncated KRAB-A subdomain were found in protein complexes containing TRIM28. 
Importantly, all ZNF746b segments showed substantially higher repression activities as 
compared to their counterparts of ZNF746a and their repression activities significantly 
dropped in HAP1 knockout cell models depleted of TRIM28 or SETDB1. The gained 
repression activities in the protein segments with non-truncated KRAB-A occur mainly 
through the canonical mechanisms known for the KRAB domain. The fact that the amino-
terminal segments of ZNF746 could maintain some repression activities in TRIM28 knockout 
cells suggests the existence of TRIM28-independent regulatory mechanisms. The moderate 
repression activity of the full KRAB domain of ZNF746b compared to the ZNF10 KRAB 
domain turned out to be predominantly due to the absence of a glutamic acid residue that is 
highly conserved in the canonical KRAB-A consensus within the so-called “MLE”-motif. In 
agreement with the canonical model of KRAB function, the replacement of glycine residue 
with the glutamic acid residue in ZNF746b-KRAB concomitantly increased complex 
formation with TRIM28 as well. Apparently, N-terminal domain configurations including 
DUF3669 and controlled by SUMOylation events appear to determine protein complex 
formation of DUF3669-containing KRAB-ZNF proteins and to mediate transcriptional 
repression. The observed oligomerization property of DUF3669 is proposed to facilitate the 
forming of regulatory protein assemblies with other DUF3669 containing KRAB ZNF 
proteins. In addition, occurring SUMOylation might confer an additional docking surface to 
stabilize complex formation with TRIM28 or directly attract other chromatin modifiers such 
as SETDB1 or HDAC. Additional research activities are necessary to confirm whether 
endogenous genomic targets might be regulated in a comparable fashion as initially shown by 
the reporter assays. Moreover, the DUF3669 oligomerization function determined in this 
study underlines that KRAB-ZNF proteins acquired highly sophisticated regulatory properties 
by employing additional protein domains. The conservation of SUMO-receptor lysines in 
other DUF3669-containing zinc finger proteins suggests common intrinsic regulatory 
mechanisms for functions in distinct cellular processes from cell cycle regulation to cellular 
differentiation. This comprehensive study presents an entry to the phylogeny of DUF3669 
containing KRAB-ZNF proteins and might be supportive in answering how KRAB mediated 
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2-  Introduction 
2.1- Regulation of gene expression 
Many mechanisms orchestrate gene expression to maintain the basic biological and metabolic 
function of an organism. Eukaryotic genes are transcribed under the control of promoter, 
enhancer, and silencer elements. While promoters reside near the 5’ end of the gene, 
enhancers and silencers are located down- or upstream from their target genes ( Maston et al., 
2006; Chatterjee and Ahituv, 2017) and in intronic sequences as well (Deng et al., 2017; 
Finkbeiner, 2001). Sequence-specific transcription factors can bind to promoters, enhancers 
(activators), or silencers (suppressors) and modulate the recruitment of RNA polymerase II to 
the promoter and thereby regulate the rate of gene transcription (Martinez, 2002). Regulation 
of gene expression occurs either by direct targeting of the basal transcriptional machinery or 
by modulating the DNA-packaging structure (chromatin). It is thought that activators can 
recruit the transcription machinery to the promoter or enhance conformational changes in the 
complex. The suppressors may prevent the transcription by competing with transcription 
machinery components in binding to the promoter (Chatterjee and Ahituv, 2017) and/or 
through chromatin marks (Dillon et al., 2005).  
In eukaryotes, DNA is packaged into chromosomes that are made up of repetitive units called 
“nucleosomes”. Each nucleosome is made up of an octamer core of histones (two dimers of 
H3: H4, and two dimers of H2A: H2B) (Campos and Reinberg, 2009). Histone amino-
terminal tails are highly conserved and heavily prone to post-transitional modifications (PTMs) 
that can lead to reversible changes in nucleosome assembly and DNA accessibility (Bannister 
and Kouzarides, 2011). For example, histone lysine acetylation is usually associated with 
transcriptional activation, presumably by weakening the electrostatic interactions between 
lysine residues and the phosphate backbone of DNA (Allfrey et al., 1964; Hebbes et al., 1988). 
Histone arginine methylation serves as either a transcriptional activating mark or 
transcriptional repressive mark dependent on the targeted arginine residue (Di Lorenzo and 
Bedford, 2011). Histone lysine methylation is catalyzed predominantly by SETdomain–
containing methyltransferase family which targets multiple lysine residues such as; H1K26, 
H3K4, H3K9, H3K27, H3K36, and H4K20 resulting in transcriptional activation or inhibition 
depending on targeted residue (Dillon et al., 2005). H3K9me forms a high-affinity mark for 




proteins and making the target promoter inaccessible to the transcription machinery (Schultz 
et al., 2001, 2002).  
2.2- C2H2 zinc finger transcription factors 
The C2H2 “Krüppel”-class zinc finger (ZNF) family represents the largest group of 
transcription factors in human (Vaquerizas et al., 2009). Already back in 1990 with the 
description of the C2H2 KOX gene family, the expression of about 70 C2H2 zinc finger 
genes was estimated to occur in human T cells (Thiesen, 1990). Most ZNF proteins are 
transcriptional regulatory proteins that are involved in important cellular processes, such as 
proliferation, development, differentiation, speciation, and cancer pathology. ZNF proteins 
often contain tandem repeats of about 30 amino acids long finger-like motifs connected by 
short polypeptide linkers (Thiesen, 1990; Wolfe et al., 2000).  
The zinc finger motif is folded in a short ßß-hairpin-alpha helix compact domain. Zinc cation 
stabilizes this structure through direct interaction with two Cys at one end of the ß-sheet and 
two His in the C-terminal part of the alpha helix (Thiesen, 1990; Thiesen and Bach, 1990, 
1991a).  
The amino acids of the α-helix are the major determinants for DNA binding and its specificity 
(Thiesen and Bach, 1991b; Thiesen and Schröder, 1991) supporting the notion of a zinc finger 
recognition code (Thiesen, 1990). Each zinc finger can bind three to four nucleotides within 
the major groove of DNA; the amino acids in the positions +6, +3, and -1 in the alpha-helix 
bind first, second, and third nucleotides at 5’ end, respectively. The amino acid +2 binds the 
fourth nucleotide in the complementary strand (Urnov et al., 2010; Gutierrez-Guerrero et al., 
2018). 
The diversity of amino acid sequences of zinc finger, the number of zinc finger motifs, 
spacing of zinc finger motifs, and higher-order structure increase the ability of zinc finger 
domain to bind a wide range of ligands that are not only DNA sequences, but also DNA-RNA 
hybrids, lipids, and proteins (Eom et al., 2016; Fedotova et al., 2017). Currently, designer zinc 
finger is used in genome editing as engineered zinc finger nucleases ( Urnov et al., 2010; 




2.3-  Krüppel associated box (KRAB)–containing zinc 
finger protein family  
2.3.1-  Discovery 
The KRAB domain was initially discovered in December 1988 as heptad repeat of leucines in 
resemblance to the protein interaction domain found in leucine zipper structures as mentioned 
in the Annual Report 1988 of the Basel Institute of Immunology and published by Thiesen in 
1990 and by Thiesen and Meyer in 1993. Sequences encoding the Krüppel-associated box 
(KRAB) domain are present in more than 400 of at least 742 human ZNF genes (Huntley et 
al., 2006). The earliest description in the literature of what was later coined KRAB domain 
was as N-terminal “heptad repeat of leucines” after analyzing KOX1/ZNF10 in 30 non-
overlapping cDNAs of cKox1 to cKox30 isolated from human T-cells (Thiesen, 1990). 
Shortly thereafter, the name “KRAB domain” was coined referring to a highly conserved 75aa 
domain located at N-termini of numerous ZNF proteins from various species (Bellefroid et al., 
1991; Thiesen et al., 1991). Importantly, several subsequent studies revealed the 
transcriptional silencing capacity of KRAB domains when they were tethered to DNA via a 
DNA binding domain in heterologous reporter assays (Margolin et al., 1994; Pengue et al., 
1994; Witzgall et al., 1994; Deuschle et al., 1995; Pengue and Lania, 1996). 
2.3.2- Genomic organization and protein domain configuration  
Typically, the KRAB domain is made up of canonical subdomain A with or without an 
additional C-terminal subdomain. The most prevalent class of the KRAB-ZNF proteins 
harbors N-terminal KRAB-A and KRAB-B subdomains and C-terminal ZNF motifs (Fig. 1; 
(Huntley et al., 2006)). It was reported that KRAB-A confers repression activity while the 
KRAB-B enhances the KRAB-A mediated transcriptional repression through an unknown 
mechanism (Vissing et al., 1995). In addition to KRAB-A and KRAB-B subdomains, other 
subdomains have been characterized; KRAB-b which is a highly divergent KRAB-B (Mark et 
al., 1999), KRAB-C (Looman et al., 2004) and KRAB-BL (about10 amino acids longer, 
extending towards the C-terminal direction) (Huntley et al., 2006). Corresponding the 
evolution of KRAB-A, the KRAB-B coding-exon diverged into KRAB- b in some KRAB 
ZNF genes and might have been completely lost in others (Looman et al., 2002). While the 
KRAB subdomains are encoded by individual exons separated by introns with variable sizes, 
zinc finger domains containing multiple zinc fingers are encoded by a single exon (Fig. 1 




major genomic clusters, the largest cluster resides on human chromosome 19 ( Rousseau-
Merck et al., 2002; Huntley et al., 2006). The multi-exon configuration of KRAB-ZNFs 
proteins led to the acquisition of new protein domains; such as SCAN and DUF3669 domains 
These accessory domains are found in the amino termini of several highly evolutionarily 
conserved KRAB-ZNFs (Ecco et al., 2017). 
 
Fig. 1:  Examples of gene models and primary protein structures of some KRAB-ZNF proteins 
represent different subclasses of KRAB-ZNF protein family; KRAB AB-ZFs (e.g. ZNF10), 
DUF3669-KRAB AB-ZFs (e.g. ZNF746), SCAN-KRAB AB-ZFs (e.g. ZNF215), and KRAB A-ZFs (eg. 
ZNF114).  
2.3.3- Molecular mechanisms of canonical KRAB-mediated 
transcriptional repression 
It is widely believed that the interaction between the KRAB domain and TRIM28 is 
obligatory and direct to function as a transcriptional repressor (Deuschle et al., 1995; Lupo et 
al., 2013). TRIM28 has initially been visualized as silencing –mediated protein (SMP1) and 
as a binding partner of the KRAB domain of Kox1 by (Deuschle et al., 1995). This interaction 
occurs directly through the N-terminal RBCC motif of TRIM28 (Fig. 2) (Friedman et al., 
1996; Peng et al., 2000a; Peng et al., 2000b). Recent data showed that TRIM28 forms 
antiparallel dimers via the coiled-coil domain which primers higher-order assembly of 




RBCC on the dyad of the RBCC dimer that is required for transcriptional repression. The 
higher oligomerization status of TRIM28 did not affect its transcriptional silencing potential 
(Stoll et al., 2019). 
 
Fig. 2: TRIM28 from Homo sapiens; primary structure and post-translational modifications. The 
amino-terminal RBCC motif (RING, B1box, B2box, and coiled-coil) is responsible for the interaction 
with the KRAB domain. The amino-terminal PHD-BR is responsible for recruiting SETDB1 and NuRD 
complex to the target genomic locus. HP1-BD is responsible for binding heterochromatin protein 1 
(HP1) through its binding site (PxVxL). TRIM28 is SUMOylated at the indicated lysines (K) and 
phosphorylated at the indicated serines (S), adapted from (Czerwińska et al., 2017). 
The C-terminal Plant Homeodomain (PHD) finger and bromodomain (referred collectively as 
PHD-BD) are the responsible parts for gene silencing. Isolated PHD-BD served as a repressor 
when it was tethered to DNA using a heterologous DNA-binding domain (H. Peng et al., 
2000). PHD-BD binds CHD3/Mi-2alpha subunit of NuRD/HDAC complex (Schultz et al., 
2001) and histone methyltransferase SETDB1 enzyme (Schultz et al., 2002). In addition, a 
central domain in TRIM28 called HP1BD (HP1 protein binding domain) containing a core 
PxVxL motif binds directly to the chromoshadow domain of the HP1 protein (Lechner et al., 
2000). 
SETDB1 (SET domain bifurcated 1) contains SET domain interrupted by an evolutionarily 
conserved 347-amino-acid insertion to form two functionally distinct subdomains (Harte et al., 
1999; Schultz et al., 2002). SETDB1 specifically methylates the lysine 9 in the N-terminal tail 
of histone 3 (H3K9me), while inactive toward histone H2A, H2B and H4 (Schultz et al., 2002; 
Yang et al., 2002) to form a high-affinity mark for the recruitment of HP1 protein which 
facilitates the deposition of HP1 proteins (Schultz et al., 2002, 2001). ATF7IP (also known as 
MCAF1or hAM) is a SETDB1 interacting protein in humans and promotes the conversion of 
H3K9me2 mediated by SETDB1 to H3K9me3 in vivo (Wang et al., 2013). 
It has been reported that the PHD domain in TRIM28 serves as intramolecular E3 SUMO 
ligase SUMOylating its cognate bromodomain. This SUMOylation event turns to be essential 




TRIM28 was shown not to be affected by TRIM28 SUMOylation status. The SUMO 
Interacting Motifs (SIM) of SETDB1 and CHD3 have been identified; 122-IIEI-125 and 
1995-VICI-1998 respectively (Fig. 3) (Ivanov et al., 2007; Mascle et al., 2007). 
 
Heterochromatin protein-1 is made up of two distinct evolutionary conserved domains; 
amino-terminal chromodomain (CD) and carboxy-terminal chromoshadow domain (CSD), in 
addition to the non-conserved central region that possesses DNA binding properties (hinge 
region). HP1 binds H3K9me3 marks with high affinity (Bannister et al., 2001).  
It has been reported as well that CSD forms a strong homodimer and interacts with TRIM28 
in the stoichiometry of 2:1 (Lechner et al., 2000). HP1 plays an essential role in the 
KRAB/TRIM28 repression model. CSDs form a strong dimer, while CDs form a weak 
tetramer. Two CDs recruit two H3K9me3 marks on the surface of the nucleosome and the 
other two CDs are still unoccupied to form bridges by recruiting additional H3K9me3 marks 
Fig. 3: Model for KRAB-TRIM28 mediated transcriptional repression. The KRAB-ZNF protein 
binds specifically to a chromatin locus via its zinc finger (ZF) motifs. The KRAB domain interacts 
with RBCC motif of the nuclear multimodular hub protein TRIM28. TRIM28 recruits chromatin- 
modifying complexes via its carboxyl repressive part. Auto-SUMOylation is apparently essential  for   
TRIM28-mediated transcriptional repression. The SUMOylated sites are docking interfaces for 
CHD3, a component of NuRD complexes with its associated activities like histone deacetylases 
(HDACs), and the histone methyltransferase SETDB. The HDACs remove histone acetyl marks while 
SETDB1 methylates H3K9 residues. Heterochromatin protein HP1 recognizes H3K9me marks 
placed by SETDB1 and triggers heterochromatization at targeted locus making it non-permissive for 




on the adjacent nucleosome. In this way, HP1 proteins spread along the chromatin fibers and 
these spreads are directed by H3K9me3 marks (Canzio et al., 2011). 
A gene-trapping method suggested that KRAB-TRIM28 transcriptional silencing machinery 
can repress genes that are located far away from their primary docking sites (Groner et al., 
2010). How KRAB-ZNFs select their genomic targets along this distance for transcriptional 
repression and how a silenced locus can be converted back to a chromatin configuration that 
is again permissive for transcription, these topics are still ill-defined. Meylan and coauthors 
demonstrated that genes most susceptible to KRAB/TRIM28-mediated transcriptional 
repression are located in genomic regions of high gene activity. Furthermore, the pre-
existence of H4K20me3 and H3K9me3 marks at the promoter and the surrounding region are 
assumed to make the promoters more susceptible to KRAB/TRIM28-mediated transcriptional 
repression (Meylan et al., 2011). In addition, KRAB/TRIM28 machinery seems to auto-
regulate the KRAB-ZNF genes as well. As such, the KRAB-TRIM28 binding sites are located 
predominantly near 3’ end and within the transcribed region of KRAB-ZNF genes. This 
binding mediates the spread of heterochromatin along the chromatin body (Groner et al., 2010; 
O’Geen et al., 2007). 
2.3.4- The biological function of KRAB-ZNF proteins 
It was recently proposed that tandem zinc finger genes originally evolved to repress the 
transcription of transposable elements (TE). It is like an ‘’arms race’’ against these fossilized 
genetic invaders. In several vertebrate genomes, a striking correlation between the number of 
TE elements and ZNF genes has been observed. Additionally, it was hypothesized that there 
was a selective pressure to preserve KRAB-ZNFs-TEs pairs after the expansion of these TEs 
for millions of years. (Imbeault et al., 2017; Thomas and Schneider, 2011). The majority of 
KRAB-ZNF-binding sites of the human genome are located within TEs, and one-third of 
KRAB-ZNFs bind other genomic targets such as promoters or DNA repeats (Imbeault et al., 
2017). Over the course of evolution, the number of zinc finger motifs per protein increased. 
These added motifs could be functional or non-functional motifs (Looman et al., 2002).  
Due to their numerical abundance, the KRAB-ZNF proteins have the potential to form a 
complex regulatory network that controls the transcription of a wide category of genes and 
hereby diverse biological processes (Fig. 4). Although the identification of the endogenous 
targets of all KRAB-ZNFs is far from being clearly assessed, a lot of evidences have been 
accumulated by now, indicating the importance of KRAB-ZNF proteins and KRAB/TRIM28 




KRAB/TRIM28 controls the retroelements during early embryogenesis. Upon DNA specific 
binding of KRAB-ZNF/TRIM28 and subsequent trimethylation of H3K9, specific DNA 
methylation of endogenous retroviral sequences occurs. These DNA methylation events are 
thought to encounter the indiscriminate genome-wide DNA methylation and permanently 
silence thousands of retroelements during development without the need for constant 
KRAB/TRIM28 recruitment (Quenneville et al., 2012; Rowe et al., 2013). KRAB/TRIM28 
regulatory pathways are also implicated in metabolic control; for example, human ZNF224 
represses the human aldolase A gene in KRAB/TRIM28-dependent manner and recruits 
arginine methyltransferase PRMT5 to the promoter that regulates the glycolysis pathway 
(Cesaro et al., 2009). Many KRAB-ZNFs are involved in the development of the adaptive 
immune system in humans (Santoni de Sio, 2014). Few studies pointed out the role of KRAB-
ZNF proteins in neurodegenerative diseases. ZNF179 is a brain-specific protein and the 
inhibition of ZNF179 expression downregulates neuronal differentiation in P19 embryonal 
carcinoma cells and cerebellar granule cells (Pao et al., 2011). ZNF224 has been shown to 
influence intermediate phenotypes associated with Alzheimer's disease (Shulman et al., 2010), 
ZNF746 is implicated in Parkinson's disease pathology (see section 2.5.1).  
Overexpression of several KRAB-ZNF proteins has been linked to oncogenesis; for example, 
the analysis of RNAseq profiling datasets of 16 different cancer types in The Cancer Genome 
Atlas (TCGA) project revealed a subset of 16 KRAB-ZNFs that are shown to be commonly 
upregulated (Machnik et al., 2019). Despite a large number of studies linking KRAB-ZNF 
proteins with biological and pathological pathways, the underlying molecular mechanisms are 





Fig. 4: Functions of the KRAB-ZNF/TRIM28 system or KRAB-ZNF in cellular physiology based 
on scientific literature.  
2.4- The domain of Unknown function 3669 (DUF3669)  
Conserved protein domains that have as yet unknown activities and biological properties are 
grouped in the Pfam database into subgroups of “domains of unknown function” using the 
prefix “DUF” followed by a number (a full list of DUFs can be found at 
http://pfam.xfam.org/family/browse?browse=d and https://www.uniprot.org/docs/upflist) 
(Mudgal et al., 2015). DUF3669 (protein domain identifier; PF12417) is described in InterPro 
database (https://www.ebi.ac.uk/interpro/beta/entry/InterPro/IPR022137/) as a 64 -80 amino 
acids domain. DUF3669-containing KRBA-ZNFs form a subfamily of six members that 
reside in the same cytogenetic location (7q36.1) in the human genome, which suggests that 
these genes have arisen from a common ancestral gene through internal duplication events. 
It has been postulated that DUF3669-containing KRAB-ZNFs more likely bind to promotor 
regions (Imbeault et al., 2017). Note, all human DUF3669-containing KRAB-ZNFs are 
conserved between human and opossum. By excluding human SCAN-containing KRAB-ZNF 
genes, the genome-wide analysis showed that only three human KRAB-ZNF genes have 
orthologous proteins in nonmammalian amniote groups. These genes are DUF3669-
containing KRAB-ZNFs (ZNF282, ZNF777, and ZNF783). In addition, multiple alignments 
of these orthologs revealed that their KRAB-A boxes lack the conserved LE residues within 
MLE sequence that are required for TRIM28 recruitment suggesting that DUF3669-




DUF3669-containing KRAB-ZNFs are clustered in chr7; cytogenetic band 7q36.1(Liu et al., 
2014). 
Low homology sequences covering all metazoan taxa and fungi have been included to define 
DUF3669 consensus. The resulting domain model looks rather degenerated with a low 
number of strongly conserved amino acid residues just at the borders 
(https://www.ncbi.nlm.nih.gov/Structure/cdd/pfam12417). 
2.5- Zinc finger protein 746 (ZNF746/PARIS) 
Human ZNF746 is also known as PARIS (Parkin interacting substrate). Its protein 
configuration is characterized by an N-terminal DUF3669 followed by a KRAB domain with 
KRAB-A and KRAB-B subdomains and a C-terminal array of four zinc fingers (Fig. 10). The 
KRAB-A subdomain of the major ZNF746 isoform (designated ZNF746a throughout this 
thesis) has a 15aa truncation at its amino terminus. The repressive activity of ZNF746 is 
regulated by SUMOylation: In vivo and in vitro SUMOylation assays showed that ZNF746 is 
SUMOylated primarily at K189 and K286 (Nishida and Yamada, 2016). ZNF746 interacts 
specifically with Protein Inhibitor of activated STATy (PIASy) that functions as SUMO 
ligase E3 (Nishida and Yamada, 2016). Reporter assays showed that SUMOylation plays an 
essential role in the repression of PGC-1α promoter in a cell-dependent manner (Nishida and 
Yamada, 2016). 
2.5.1- The role of ZNF746/PARIS in Parkinson’s disease 
Several studies pointed out the role of ZNF746 in mitochondrial biogenesis and glucose 
metabolism in dopaminergic neurons. ZNF746 overexpression has a deleterious effect on 
dopaminergic neurons and is a part of the physiological condition that regulates mitochondrial 
homeostasis, controlling both degradation and biogenesis. 
ZNF746 binds the Insulin response sequence (IRS) region in the promoter of the peroxisome 
proliferator-activated receptor-gamma (PPARγ) coactivator-1a (PGC-1α) gene and represses 
the expression of PGC-1α in human cells, mouse brain, and the human brain. (Shin et al., 
2011; Stevens et al., 2015). The downregulation of PGC-1α gene resulting from 
overexpression of ZNF746 in adult animal mice led to selective loss of dopaminergic neurons 
in the substantia nigra (Shin et al., 2011). 
The levels of ZNF746 are regulated by the parkin ubiquitin-proteasome system through 




proteasomal degradation. The C-terminus of ZNF746 (Zinc finger motifs) binds to either the 
RING1 or RING2 domain of Parkin. Thus, PARKIN-ZNF746 seems to be an integral unit to 
maintain the mitochondrial homeostasis (Shin et al., 2011). It was reported that PTEN-
induced putative kinase 1 (PINK1) directly phosphorylates serines 322 and 613 of ZNF746 
and this phosphorylation is necessary for PARKIN-mediated ubiquitination of ZNF746 and 
thereby proteasomal degradation of ZNF746 (Fig. 5) (Lee et al., 2017). A reduction of 
mitochondrial number and abnormal appearing cristae in a significant fraction of 
mitochondria in adult conditional Parkin knockout mice. The knockdown of ZNF746 could 
substantially and significantly reverse and prevent these effects (Stevens et al., 2015). 
In addition to PGC1α, Transketolase (abbrev. TKT; a key enzyme of pentose phosphate 
pathway glucose metabolism in all organisms) has been identified as an endogenous target of 
ZNF746. The overexpression of ZNF746 led to a significant reduction of TKT promoter 
activity in human cell lines that was reversed by parkin co-overexpression. The protein and 
mRNA levels of transketolase (TKT) specifically decreased in the dopaminergic neurons of 
the substantia nigra in mice but not in the cortical neurons of the cortex of AAV-ZNF746 
mice. It was also reported that TKT mRNA levels decreased in the substantia nigra of 
Parkinson's disease patients. ZNF746 overexpression suppresses TKT transcription via the 
IRS-like motif in the TKT promoter (Kim et al., 2017). The ZNF746-mediated inhibition of 
the pentose phosphate pathway by repression of TKT resulted in the induction of HIF-1α that 






Fig. 5: ZNF746 plays a harmful role in dopaminergic neurons in the substantia nigra, and its levels 
are regulated by PARKIN-mediated ubiquitination. ZNF746 downregulates the expression of 
transketolase and PGC-1α in dopaminergic neurons of the substantia nigra. Aberrant accumulation of 
ZNF746 results in impairment of mitochondrial biogenesis and energy metabolism leading to 
dopaminergic neurons death and development of Parkinson's disease. PINK-1 interacts directly with 
ZNF746 and phosphorylates it at S322 and S613. The phosphorylation events promote the interaction 
of ZNF746 with PARKIN E3 ubiquitin ligase. The ubiquitinated ZNF746 is eliminated by proteasomal 
degradation. 
 
2.5.2- The role of ZNF746/PARIS in cancer 
ZNF746 is overexpressed in human colorectal cancer cells and colorectal cancer tissues. The 
overexpression of ZNF746 was correlated with reduced cellular survival. Accordingly, the 
depletion of ZNF746 suppressed the growth of colorectal cancer, lung, and breast cancer cells. 
ZNF746 interacts with the proto-oncogene protein c-Myc and co-localizes with c-Myc in the 
nucleus of human colon cancer cells (HCT116) (Jung et al., 2018). It was reported that the 
silencing of ZNF746 in H460 non-small cell lung cancer cells (H46 NSCLC) leads to 
inhibition of matrix metalloproteinase; MMP1, MMP2, and MMP9 that are known to promote 
tumor survival, invasion as well as metastasis (Kim et al., 2014). Chen and coauthors 
provided evidence on the role of ZNF746 in bladder cancer in vivo and in vitro. It was shown 
that the silencing of ZNF746 in bladder cancer cells resulted in significant suppression of 
their growth and invasion. In addition, the silencing of ZNF746 led to the downregulation of 
Protein kinase B (also known as AKT), and Matrix metalloproteinase 9 (MMP-9) (Y.-T. Chen 




2.6- Zinc finger protein 777 (ZNF777) 
ZNF777 is a paralog of ZNF746 and shares a similar primary structure (DUF3669-KRAB 
AB- Zinc finger motifs), see Fig. 10. In comparison to ZNF746, the physiological functions 
and transcriptional repressive potential of DUF3669-KRAB-ZNF protein ZNF777 are far less 
understood. Quantitative RT-PCR and immunohistochemistry staining showed that ZNF777 
is highly expressed in the human placenta (Liu et al., 2014). ZNF777 is localized to the 
nucleus through its zinc finger domain and shown to be responsible for inhibition of cell 
proliferation at low density (Yuki et al., 2015). The expression of ZNF777 resulted in 
decreasing levels of FAM129A (Family with sequence similarity 129 member A) at mRNA 
and protein levels which can partly be involved in inhibition of cell proliferation mediated by 
ZNF777 especially at low cell density (Yuki et al., 2015). 
 
2.7. Haploid HAP1 cells – an efficient knockout model to 
study cellular functions  
With the advent of CRISPR/Cas9-based genome engineering strategies, genes and gene 
segments can be removed or replaced. However, in diploid mammalian cells, the limitation of 
the mutagenesis methods is that the resulting mutants are usually heterozygotes, which can 
mask recessive phenotypes. The desired phenotype of a loss of function mutation on one 
chromosome is not displayed unless the sister chromatid is also mutated. This limitation is 
circumvented if haploid or nearly haploid cells are engineered utilizing CRISPR-Cas9 
strategies. 
HAP1 cells are a near-haploid cell line derived from the KBM-7 cell line that could be stably 
grown over at least three months. This cell line is characterized by the haploidy of all 
chromosomes with the exception of Chr.8 and a 30-megabases fragment of the Chr.15 
(Kotecki et al., 1999). The haploidy property was harnessed to perform large-scale loss of 
function screens in human cells(Carette et al., 2009). Later on, the HAP1 cell line was 
generated with a haploidy of Chr.8. Such cells are not fully haploid, however, since they 
contain two copies of a portion of Chr.15, one of which is incorporated into the Chr.19 
(Carette et al., 2011). This fragment was deleted from the Chr.19 in order to gain a fully 




Because HAP1 cells contain only one allele of each gene, they have the advantage of fast 
functional gene identification. Therefore, the HAP1 cells have been applied across a wide 
range of biological processes, such as DNA damage repair (Xing and Oksenych, 2019), drug 
sensitivity (Gerhards et al., 2018), and immune response (Keskitalo et al., 2019).  
It has been observed that haploid HAP1 cells ‘’ diploidized’’ after several passaging circles 
through endoreduplication events (Essletzbichler et al., 2014), the loss of haploid cells is due 
to their limited viability. Thus, they replace themselves by an overgrowth of existing diploid 
cells in the cultures (Olbrich et al., 2017). Here, HAP1 cells deleted either of TRIM28 or 







This study focuses on the DUF3669-containing KRAB-ZNF protein subfamily. Two human 
members of this subfamily, ZNF746 and ZNF777, have been selected for a detailed study. 
Because of the clinical significance of ZNF746, better understanding of molecular 
mechanisms of action might open the door on new diagnostic and therapeutic aspects. 
ZNF777 belongs to the oldest evolutionarily conserved KRAB-ZNFs. 
The aim of this work was to investigate the impact of the amino-terminal domain array of two 
DUF3669-containing KRAB-ZNF proteins; ZNF746 and ZNF777 on their transcription factor 
properties. In addition, this study purposed to evaluate the contribution of the canonical 
KRAB/TRIM28 pathway to the ZNF746- and ZNF777-mediated repression activities. 
The experimental approaches in this study relied on classical DNA cloning methods, 
luciferase reporter assay, co-immunoprecipitation, and affinity pull-down assay. 
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4- Materials and methods 
4.1- DNA techniques and cloning 
4.1.1- RT-PCR (Reverse transcription PCR) 
The coding sequences for several protein regions of ZNF746 and ZNF777 were synthesized 
by RT-PCR from RNA derived from the human fetal brain (Clontech #64094-1, 1mg/ml; 
pooled from 24 male/female Caucasians) and human testis (Clontech #64101-1, 1mg/ml; 
pooled from 45 Caucasians age 19-64) unless otherwise stated. High Capacity cDNA Reverse 
Transcription Kit with RNA inhibitors (Applied Biosystems, Cat. No. 4374966) was used. 
Table 1: Preparation of reaction mixture for one reaction. 
Components  Volume for 1x reaction 
10x RT Buffer  2µl 
25x dNTP Mix  0.8 µl 
10x RT Random Primers 2µl 
MultiScribe Reverse Transcriptase 1µl 
RNase Inhibitor 1µl 
molecular biology grade nuclease-free H2O 3.2 µl 
 
The reaction mixtures were vortexed, quickly centrifuged at 4° C, and mixed with 10µl of 0.1 
µg/µl total RNA solution (by pipetting). The reaction mixtures were incubated in the 
thermocycler at; 25°C for 10 min / 37°C for 120min / 85°C for 5min / 4°. 
4.1.2- Specific PCR (DNA amplification) 
Enzyme PfuUltra II Hotstart DNA polymerase (Stratagene/Agilent Cat. No. 600670) was used 
for PCR, together with the proprietary Pfu Ultra II reaction buffer and a 10mM dNTP mix 
(2.5mM each of deoxyadenosine/deoxyguanosine/ deoxycytidine/deoxythymidine 
triphosphate). 
Table 2: Pipetting plan of PCR using PfuUltra II HS Stratagene. 
Component Needed volume  
dNTPs (stock 2.5mM) 6 µl 
10 x PfuUltra II buffer 5 µl 
PfuUltraII Fusion  HS DNA polymerase  (2.5 U/µl) 2 µl 
cDNA (template) Equiv. 200ng RNA or 10ng of plasmid 
*Primers (Forward and reverse) 0.5µl+0.5µl 
Nuclease-free H2O  Up to 50µl 
* Primers are listed in Table 4 
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4.1.3- Purification of PCR products 
PCR amplicons with flanking restriction sites were purified via MinElute Reaction Clean up 
kit (50), Cat. No.28204;  
• 300μl buffer ERC were added to the enzymatic reaction and mixed. 
• The samples were applied to the MinElute column and centrifuged for 1 min/16060 x 
g.  
• 750μl buffer PE were added to the MinElute column and centrifuged for 1 min/16060 
x g.  
• Flow-through was discarded and the column was centrifuged again for 1 min/16060 x 
g.  
• Additional 1 min centrifugation step was done to ensure the removal of residual 
ethanol from buffer PE. 
• In a clean 1.5 ml micro centrifuge tube, DNA was eluted by adding 10μl water to the 
center of the MinElute membrane and centrifuging 1 min at 16060 x g.  
• The purified PCR amplicons were size-controlled on an agarose gel. (16060 x g = 
13000 rpm; Heraeus biofuge fresco). 
 
Table 4: List of primers used for PCR. Lowercase letters; overhangs that contain restriction sites, 
uppercase letters; coding sequence. The positions of the oligonucleotides in ZNF746 and ZNF777 
exons are indicated relative to the nucleotide position; ZNF746 (isoform a: NM_152557.4 and isoform 
b: NM_001363517.1) and ZNF777 (NM_015694.3). 
Name Position  PCR primers 
Z746a/94-173 nt 551-790  5’-ccgctcgagtTGGATCCTGCGGCTGCC-3’ 
3’-acgcgtcgactaTGGACTGGGGTCCACAGGAA-5’ 
Z746a/1-279 nt 272-1108 5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
3’-acgcgtcgactaTTCCGTGGAGGCTGCTGT-5’ 
Z746a/1-173 nt 272-790 5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
3’-acgcgtcgactaTGGACTGGGGTCCACAGGAA-5’ 
Z746a/94-279 nt 551-1108 5’-ccgctcgagtTGGATCCTGCGGCTGCC-3’ 
3’-acgcgtcgactaTTCCGTGGAGGCTGCTGT-5’ 
Z746a nt 272-2206 5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
Cycles Temp [°C] t 
1 95 2 min 
5 95 30sec 
62 30sec 
72 1 min 
30 95 30 sec 
65 2 min 
72 1 min 
End 72 5 min 
4 ∞ 




Z746a/174-279 nt 791-1108 5’-ccgctcgagtGGCTCGGGGCC-3’ 
3’-acgcgtcgactaTTCCGTGGAGGCTGCTGT-5’ 
Z746a/280-644 nt 1109-2206 5’-ccgctcgagtATGgATGTAAAAATTGTAATAAAAACAGA-3’ 
3’-cgcgtcgacTCACATGTCCCCGCCAT-5’ 
Z746a/1-108 nt 272-595 5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
3’-acgcgtcgactaCTTAGGGGACTCCCCCTTGC-5’ 
Z746b/109-188 nt 598-837 5’- ccgctcgagtGTGCCCGTGACCTTTGATGATG -3’ 
3’-acgcgtcgactaTGGACTGGGGTCCACAGGAA-5’ 
Z746b/1-294 nt 274-1155  5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
3’-acgcgtcgactaTTCCGTGGAGGCTGCTGT-5’ 
Z746b/1-188 nt 274-837 5’-ccgctcgagtATGGCCGAGGCGGTCG-3’ 
3’-acgcgtcgactaTGGACTGGGGTCCACAGGAA-5’ 
Z746b/109-294 nt 598-1155 5’- ccgctcgagtGTGCCCGTGACCTTTGATGATG -3’ 
3’-acgcgtcgactaTTCCGTGGAGGCTGCTGT-5’ 
Z777/283-362 nt 1110-1350 5’-ccgctcgagtGTCCCTGTCACATTTGATGATGT-3’ 
3’-acgcgtcgactaAGCACTGGGATCTGTCGG-5’ 
Z777/1-362 nt 264-1350 5’-ccgctcgagtATGGAGAACCAACGCTCATC-3’ 
3’-acgcgtcgactaAGCACTGGGATCTGTCGG-5’ 
Z777/1-282 nt 264-1109 5’-ccgctcgagtATGGAGAACCAACGCTCATC-3’ 
3’-acgcgtcgactaCTTGGGAACTTCTCCATTGCT-5’ 




The T4 DNA ligase catalyzes the repair of single-stranded nicks in double-stranded DNA and 
joins double-stranded DNA restriction fragments having either blunt or sticky ends. The 
ligations were carried out for 1hr at RT using a molar ratio of 1:3 vector to insert.  
DNA fragments were size-controlled by agarose gel electrophoresis and inserted into pKS 
restricted with EcoRV (pBluescript II KS (+) GenBank X52327, Stratagene) using blunt-end 
ligation protocol, and into expression vectors were performed using sticky end ligation 
protocol. 
Table 5: Blunt- and Sticky-end ligation protocol. 
Solution  Composition Blunt-end ligation   Sticky-end ligation  
T4 DNA Ligase 
Fermentas, 
#EL0331 
5U/µl 5units = 1 µl 5 units = 1 µl 
10x T4 DNA 
Ligase Buffer 
Thermo Scientific  
# B69 
400mM Tris-HCl,100mM 
MgCl2, 100mM DTT 
5mM ATP, pH 7.8 
2 µl 2 µl 
50% PEG 
solution  
50% (w/v) polyethylene 
glycol 4000 
2 µl - 
Insert  Purified PCR product  1:3 molar ratio of insert 
over vector DNA 
1:3 molar ratio of insert 
over vector DNA 
H2O RNase free H2O Up to 20 µl Up to 20 µl 
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4.1.5- Competent bacteria and Transformation 
4.1.5.1- Media  
Table 6: Composition of media for cultivation of bacteria 
Medium Name Composition 
TY-Medium 
(Tryptone-Yeast medium)  
For 1L: 15g NaCl, 10g Yeast extract, 16g Casein 
LB-Agar 
(Lysogeny broth medium) 
For 1L: 10g NaCl, 5g Yeast extract, 10g Casein, 15g Agar-
agar 
 
Table 7: selective antibiotic agents 
Antibiotic Concentration in TY Medium Concentration on LB Plates 
Ampicillin 100µg/ml 300µg/ml 
Tetracycline 10µg/ml 30µg/ml 
Kanamycin 50µg/ml 150µg/ml 
 
4.1.5.2- Preparation of Competent Bacteria  
To make the bacteria permeable to DNA, a high concentration of Ca2+ ions was used to create 
pores in the bacterial cell membrane. E.coli XL1-Blue strain (Stratagene Catalog #200249; 
tetracycline resistant) was used for transformations and Blue-White screening. XL1-Blue cells 
are endonuclease (endA) deficient, which greatly improves the quality of mini-preparation of 
plasmid DNA, and are recombination (recA) deficient to improve the stability of the insertion. 
The hsdR mutation prevents the cleavage of cloned DNA by the EcoK endonuclease system. 
The lacIq Z∆M15 gene on the F´ episome allows the blue-white color screening.  
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIqZΔM15 
Tn10 (Tetr)].  
A single colony was picked from the LB agar plate and placed in 2ml TY medium 
supplemented with tetracycline (end concentration 10µg/ml). The bacteria were grown by 
overnight incubation in a shaker at 200 rpm and 37°C. Next day, the bacterial culture was 
expanded to 100ml by adding fresh TY–medium supplemented with 10µg/ml tetracycline in a 
Schott flask and incubated in a shaker (37°C, 200rpm) to an OD600nm ⁓ 0.3. The bacteria 
suspension was split into 2x 50ml falcon tubes and centrifuged for 10min at 2777x g (4000 
rpm; Heraeus, Megafuge® 1.0R). The supernatants were discarded, and the pellets were 
resuspended with 12ml cold 0.1M CaCl2. The tubes were incubated on ice for 10 min and 
then centrifuged again for 10min at 2777 x g, 4°C. The supernatants were discarded, and the 
pellet in one falcon was resuspended with 1ml cold 0.1M CaCl2. The suspension of the 1st 
tube was pipetted into the 2nd tube. The competent cells were stored for 2 days at 4°C.  
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4.1.5.3- Transformation  
Chemical transformation protocol was used to transform DNA plasmids into competent E-coli 
(Hanahan, 1983). The ligation mixture (20µl) was mixed with 100µl of freshly prepared 
competent cell suspension (XL1). 3 cycles of; 10min on ice incubation/ 5 min heating at 37°C 
were done. Transformation mixtures were cooled down on the ice for 1-2 minutes and then 1 
ml TY-medium was added. Cells were incubated for 15 minutes at 37 °C while shaking. 
Some or all of the transformation mixture were plated onto a 10 cm LB agar plate containing 
the appropriate antibiotic (usually, 3 plates for each transformation mixture, 200 µl for the 
first plate, 400 µl for the second, and the rest for the third plate) using a metal loop that was 
flamed beforehand. Plates were incubated upside down overnight at 37 °C.  
4.1.6- Blue-White Screening 
Blue-white screening is an efficient and rapid technique that is used to identify recombinant 
bacteria. It relies on the activity of β-galactosidase in E. coli, which cleaves lactose into 
glucose and galactose. The used cloning plasmid pKS (pBluescript II KS (+) GenBank 
X52327; Stratagene) carries a LacZ gene, which encodes α-peptide (N-terminal part of β-
Galactosidase). The E.coli XL1-Blue strain has lacZΔM15 deletion mutation, which generates 
ω-peptide. When the plasmid vector is taken up by these cells, due to the α-complementation 
process, a functional β-galactosidase enzyme is produced. The multiple cloning site (MCS) of 
pKS plasmid is located within the LacZ gene. When the coding sequence is successfully 
inserted into the plasmid, it disrupts this gene such that it is unable to produce a functional β-
galactosidase enzyme. X-Gal, a chromogenic substrate, is added to the agar plate. If β-
galactosidase is produced, X-gal is hydrolyzed and spontaneously dimerizes to produce an 
insoluble blue pigment (5, 5’-dibromo-4,4’-dichloro-indigo). 100 µl IPTG (Isopropyl β-D-1-
thiogalactopyranoside) and 100 µl of X-Gal were added on LB agar plates with the 
appropriate antibiotic. The plates were allowed to dry in the incubator, and the bacteria 
solution (transformation mixture) was added to the plates. After the drying of excess fluid, the 
plates were then incubated at 37˚C overnight. Bacteria with recombinant colonies will appear 
in white colonies, while the bacteria with non-recombinant plasmids will appear in blue 
colonies. 
4.1.7- Sanger sequencing 
While Taq polymerase extends the primer, ddNTPs (2', 3’ dideoxynucleotides) terminate the 
extension reactions because they fail to form a phosphodiester bond with the next 
deoxynucleotide. This results in randomly fragments that differ in length by one base. Each of 
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the four ddNTPs is attached with a different fluorescent dye and emits light at a different 
wavelength when excited by a laser. Taq Cycle products can be separated by capillary gel 
electrophoresis, which differ from each other with one fluorescent base and analyzed by ABI 
PRISM® 310 Genetic Analyzer according to the manufacturer’s instructions (Applied 
Biosystems). Dye-terminator chemistry and a thermostable polymerase (BigDye Terminator 
Prämix v1.1, Applied Biosystems, #4337450) were used. In a PCR tube, the following 
mixture was prepared; 2µl primer, 3µl BigDye, 2µl DNA (miniprep), up to 15µl RNase Free 
H2O. 
Taq Cyle condition: 96°C/1min- 94°C/20sec- 56°C/30sec-60°C/4min (25X) - 4°C ∞.  
DNA fragments were purified via DyeEx spin columns (DyeEx 2.0 Spin Kit, QIAGEN, # 
63204) as follows: 
• Gently vortex the spin column to re-suspend the resin 
• Loosen the cap of the column a quarter turn. 
• Snap off the bottom closure of the spin column, and place the spin column in a 2 ml 
collection tube. 
• Centrifuge for 3 min at 595 x g (2800 rpm; Heraeus biofuge fresco) at room 
temperature.  
• Carefully transfer the spin column to a clean centrifuge tube. Slowly apply the 
sequencing reaction (10–20 µl) to the gel bed. 
• Centrifuge for 3 min at 595 x g at room temperature.  
• Remove the spin column from the microcentrifuge tube (The eluate contains the 
purified DNA) 
• Dry the sample in a vacuum centrifuge (BACHOFER vacuum concentrator). 
• Dissolve the pellet with 15µl highly deionized formamide (Life Technologies 
#4311320). 
• Denature the DNA by heating the tube at 96˚ C for 2 min and then cooling the tube 
down by putting it on ice. 
• DNA sequence chromatograms were visualized by Chromas softwareVersion 2.6.5. 
 
Sequencing primers: 
M13 forward   5’-ACGACGTTAAAACGACGGCCAG (Sigma)  
M13 reverse    5’-ATTTCACACAGGAAACAGCTA  (Sigma) 
Z746_40F        5’-CCCCAGACCTCTTGATGC  (Eurogentec) 
Z746_1247R    5’-CTTGCGGAGGTGGTCCTT  (Eurogentec). 
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4.1.8- Restriction digestion of DNA  
A combination of 10x buffers and restriction enzymes (one or more) were used according to 
the supplier’s instructions for analytical and preparative digestion. For analytical purposes, the 
subcloned plasmids were restricted at certain restriction sites and the resulting fragments were 
then size controlled by agarose electrophoresis, whereas preparative digestion was used to cut 
out the desired dsDNA fragment from residual vector to be purified later from agarose gels. In 
addition, restriction digestion was applied to prepare plasmids for receiving specific 
fragments for subcloning. In a typical reaction, for analytical purposes, five units of restriction 
enzyme were used to digest about 400ng of plasmid DNA. For preparative purposes, 40 units 
of restriction enzyme were used to digest 10µg of plasmid DNA. The buffers have been 
chosen according to the manufacturer’s instructions.    
Table 8: A list of used restriction enzymes for analytical and preparative purposes. 
Restriction enzyme Composition  Restriction site  
XhoI (Thermo Scientific,#ER0691) 10 U/µl, 2000U 5’-C↓T C G A G-3’ 
3’-C A G C T↑C-5’ 
SalI (Thermo Scientific, #ER0645) 10 U/µl, 1500U 5’-G↓T C G A C-3’ 
3’-C A G C T↑G-5’ 
EcoRV (Fermentas, #ER0301) 10 U/µl, 2000U 5’-G A T↓A T C-3’ 
3’-C T A↑T A G-5’ 
HindIII (Fermentas, #ER0501) 10 U/µl, 5000U 5’-A↓A G C T T-3’ 
3’-T T C G A↑A-5’ 
BamHI (Thermo Scientific, #ER0051) 10 U/µl, 4000U 5’-G↓G A T C C-3’ 
3’-C C T A G↑G-5’ 
EcoRI (MBI-Fermentas, #ER0271) 10 U/µl, 4000U 5‘-G↓A A T T C-3’ 
3’-C T T A A↑G-5’ 
SacI (Fermentas,#ER1131) 10 U/µl, 1200U 5’-G A G C T↓C-3’ 
3’-C↑T C G A G-5’ 
BglII (Thermo Scientific, #ER0082) 10 U/µl, 2500U 5’-A↓G A T C T-3’ 
3’-T C T A G↑A-5’  
Pvu II (Boehringer Mannheim, 642 690) 10 U/µl, 1000U 5’-C A G↓C T G-3’ 
3’-G T C↑G A C-5’ 
Eco311(BsaI) (Thermo Scientific, #ER0291) 10 U/µl, 1000U 5’-G G T C T C (N)1↓-3’ 
3’-C C A G A G (N)5↑-5’ 
XbaI (MBI Fermentas, #ER0681) 10U/µl, 1500U 5’-T↓C T A G A-3’ 
3’-A G A T C↑T-5’ 
SmaI (Fermentas, #ER0661) 10U/µl, 1200U 5’-C C C↓G G G-3’ 
3’-G G G↑C C C-5’ 
NdeI (Fermentas, #ER0582) 10U/µl, 2500U 5’-C A↓T A T G-3’ 
3’-G T A T↑A C-5’ 
NaeI (Fermentas, #ER1522) 10U/µl, 1000U 5’-G C C↓G G C-3’  
3’-C G G↑C C G-5’ 
NheI (Fermentas, #ER0972)  10U/µl, 2500U  5’-G↓C T A G C-3’ 
3’-C G A T C↑G-5’ 
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Table 9: A list of used buffers 
Buffer  Composition  
Blue buffer  
(Thermo Scientific, #BB5) 
10 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2,0.1 mg/ml BSA 
Green buffer 
(Thermo Scientific, #BG5) 
10 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2,0.1 mg/ml BSA 
Orange buffer  
(Thermo Scientific, #BO5) 
50 mM Tris-HCl (pH 7.5 at 37°C), 10 mM MgCl2,100 mM NaCl, 0.1 
mg/ml BSA. 
Red buffer  
(Thermo Scientific, #BR5) 
10mM Tris HCl,10mM MgCl2,100mM KCl,0.1mg/mL BSA, pH 8.5 
Tango buffer  
(Thermo Scientific, #BY5) 
33 mM Tris-acetate (pH 7.9 at 37°C),10 mM magnesium acetate,66 
mM potassium acetate,0.1 mg/ml BSA. 
 
Table 10: Analytical and preparative digestion protocol 
Component Analytical digestion  Preparative digesion 
DNA ~400ng ~10µg 
Buffer 3µl 10µl 
Restriction enzyme 1 0.5µl 4µl 
Restriction enzyme 2 0.5µl 4µl 
H2O Up to 15µl Up to 100µl  
Incubation  1h at 37°C 4-16h at 37°C 
 
4.1.9- Agarose Gel Electrophoresis 
Electrophoresis in horizontal agarose gels is a widely used technique for separation, 
purification, and identification of plasmid DNA and DNA fragments. Due to its negatively 
charged phosphate groups, DNA migrates towards the anode in an electric field. Under 
constant voltage, linear double-stranded DNA fragments migrate inversely proportional to 
their molecular weight within a certain range. The size of a DNA fragment can be determined 
by comparison with standard DNA marker fragments of identified size. 
Depending on the size of the DNA molecules, the agarose concentration chosen was between 
1 % and 1.5 % (w/v). DNA-samples were mixed with DNA loading buffer and applied into 
the wells of the gel. TBE (Tris-borate-EDTA) or TAE (Tris-acetate-EDTA) buffers were used 
to dissolve agarose and as an electrophoretic buffer. The electrophoretic separation was done 
at 90 volts for 7.5x5.5cm gels, and at 140 volts for 18x11 cm gels. Separated fragments were 





Materials and methods 
27 
 
Table 11: Solutions of agarose gel 
Solution Name Composition 
TBE 1x for analytical gels 
(Tris-Borate-EDTA) 
 
In 1l: 10.8g Tris Base, 5.5g Boric acid 
4ml EDTA 0.5M, pH=8.0 
TAE 1x for preparative gels 
(Tris-acetate-EDTA) 
In 1l: 4.84g Tris Base, 1.142g Boric 
Acid, 2ml EDTA 0.5M,pH=8.0 
Loading buffer 7x 0.175% (w/v) bromophenol blue, 
35mM EDTA, 35% (v/v) Glycerol 
λ DNA EcoRI/HindIII marker (Thermo Scientific. # 
SM0191) 
 
Φ X174 DNA HaeIII marker (Thermo Scientific. # 
SM0251) 
0.08 μg/μl DNA,  
10mM Tris-HCl 
0.03% Bromophenol blue 





• Weigh agarose, for 1% or 1.5% gel. 
• Add 30ml 1x TBE / TAE buffer for 8 well-gel or 100ml for 28 well-gel, and 20-30ml 
H2O, and boil in the microwave. 
• Add 2µl for 8 well-gel or 6µl for 28 well-gel ethidium bromide, mix, and cast gel.  
• Electrophoresis chamber filled with 1x TBE (for analytical gel) or TAE (for 
preparative gel) buffer covering gel, add 20µl ethidium bromide for 8 well-gel or 40µl 
for 28 well-gel. 
• The samples were mixed with 7x loading buffer and loaded into agarose wells. The 
electrophoresis was run at 90V for 8-well gels, and at 140V for 28-well gels. 
• Visualization and documentation: Azure Biosystem C200 
4.1.10- DNA gel extraction  
DNA fragments with flanking restriction overhangs were purified from agarose gel via 
QIAEX® II, Gel Extraction Kit 150, #20021 
• Excise the DNA bands from the agarose gel with a clean and sharp scalpel. 
• Weigh the gel slices in colorless tubes, add QX1 buffer to the gel (300µl/100 mg gel). 
• Re-suspend the QIAEXII by vortexing 30 sec. add QIAEXII to the sample (30µl). 
• Incubate at 50˚C for 10 min to solubilize the agarose and bind the DNA, mix by 
vortexing every 2 min to keep QIAEX II in suspension. 
• Centrifuge for 30 sec at 16060 x g (13000 rpm; Heraeus biofuge fresco). 
• Wash the pellet with 500 µl of buffer QX1, vortex and centrifuge 30sec at 16060 x g. 
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• Wash the pellet with 500 µl of buffer PE, vortex and centrifuge 30sec at 16060 x g. 
Repeat this step. 
• Air dry the pellet until the pellet becomes white. 
• Elute DNA with free nuclease H2O and suspend the pellet, incubate 5 min at RT. 
• Centrifuge for 30 sec at the highest speed, the supernatant then contains the purified 
DNA. 
4.1.11- DNA precipitation 
For efficient ligation and transformation, the digestion mixture of linearized plasmids should 
be liberated from high salt concentrations.  
• Add Isopropanol and sodium acetate as follows: 1 volume digestion mix + 1 volume 
isopropanol + 0.1 volume 3M sodium acetate, vortex 
• Centrifuge at 16060 x g (13000 rpm; Heraeus biofuge fresco) for 15 min. 
• Discard the supernatant by pipetting; add 200 µl Ethanol 70% and briefly vortex. 
• Centrifuge at 16060 x g for 6 min. Repeat this washing step again.  
• Discard the supernatant by pipetting, and let the DNA to dry. 
• Dissolve the DNA in 40 µl ddH2O. 
• Detect on an agarose gel. 
4.1.12- Plasmid Isolation 
4.1.12.1- Mini-preparation of plasmid DNA from E. coli 
The plasmid mini-preparation provides a small scale, quick method to isolate low amounts of 
sufficiently purified plasmid DNA for restriction and sequence analysis. An alkaline lysis 
buffer is used to lyse the cultivated bacteria, which contains detergent SDS (to denature 
bacterial proteins) and strong base NaOH (to denature chromosomal and plasmid DNA). 
Followed by adding neutralizing buffer with sodium acetate leading to rapid reannealing of 
plasmid DNA, and precipitation of the chromosomal DNA and bacterial proteins. The soluble 
plasmid DNA was precipitated with isopropanol, and the DNA pellet was washed with 
ethanol 70% (Birnboim and Doly, 1979). 
Table 12: buffers and solutions for minipreparation plasmid isolation method 
Solution Name Composition 
Plasmid solution I 
(Resuspension buffer) 
50mM Glucose, 10mM EDTA , 25mM Tris-HCl buffer, pH 6-8 
Plasmid solution II 
(Lysis buffer) 
0,2M NaOH, 1% SDS 
Plasmid solution III 
(Neutralization buffer) 
3M Ca-Acetate, 11,5% (v/v) Acetic acid 
RNAse 10mg/ml 
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• Pick a single colony from LB agar plate and grow the bacteria in 2 ml TY medium 
(with appropriate antibiotic).  
• Overnight culture, 37°C, shake 200rpm 
• Pour the Bactria suspension into 1.5 ml tubes. 
• Centrifuge at RT, 9520 x g (10 000 rpm; Heraeus biofuge fresco) for 1min. 
• Discard the supernatant. 
• Re-suspend the pellet with 100 µl of plasmid solution I (by rubbing over a grid). 
• Add 200 µl of plasmid solution II, mix by repeated gentle inversion. 
• Add 150 µl of plasmid solution III, vortex. 
• Centrifuge at RT, 16 060 x g (13 000 rpm; Heraeus biofuge fresco) for 3min. 
• Transfer the supernatant into new tubes. 
• Add 250µl Isopropanol, mix by inverting the tubes. 
• Centrifuge at RT, 16 060 x g for 5min. 
• Discard supernatant, centrifuge briefly and discard the rest of supernatant. 
• Rinse the pellet with 200µl of Ethanol 70%, brief vortex. 
• Centrifuge at RT, 16 060 x g for 1min. 
• Discard the supernatant by using a pipette.  
• Air dry. 
• Dissolve the DNA in tubes with 50µl H2O + RNase [0.4µg/µl]. Incubate on a shaker 
at low speed about 5 min to remove the RNA.  
4.1.12.2- Midipreparation of plasmid DNA from E. coli 
For purifying plasmid DNA of higher purity and quantity, QIAGEN midi preparation kit was 
used. The method is based on QIAGEN Anion-Exchange Resin. QIAGEN plasmid buffer set 
(Qiagen #19046) and QIAfilter plasmid midi kit (Qiagen #12243, containing QIAGEN-tip 
100 anion-exchange tips and QIAfilter Midi cartridges) were used for Midi preparations. 
Table 13: QIAGEN midi prep buffers 
Name Composition 
Plasmid Solution I  
 
50mM Tris-HCl, 10mM EDTA, 100μg/ml RNAse A, pH 8.0 
Plasmid Solution II 0,2M NaOH, 1% SDS  
Plasmid Solution III 3.0 M KAc pH 5.5  
Buffer QBT 
 
750mM NaCl ,50mM MOPS, 15% Isopropyl alcohol (v/v) ,0.15 % Triton® 
X-100 (v/v), pH 7.0 
Buffer QC 
 
1.0 M NaCl, 50mM MOPS,15% Isopropyl alcohol (v/v), pH 7.0      
Buffer QF 
 
1.25M NaCl, 50mM Tris-HCl, 15% Isopropyl alcohol (v/v), pH 8.5 
 
• Inoculate 5µl of starter bacteria suspension in 50ml TY medium/antibiotic, incubate 
with shaking 200rpm at 37°C 
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• Collect the bactria culture in 50 ml tube, centrifuge at 4°C, 2778 x g (4000 rpm 
Heraeus. Megafuge® 1.0R) for 10min Discard the supernatant. 
• Add 4ml of buffer I to re-suspend the cells (Resuspension buffer). 
• Add 4ml of buffer II (lysis Buffer), mix (not vortex), wait about 5 min until the 
mixture becomes clear. 
• Add 4ml of buffer III (neutralization buffer), mix by repeated gentle inversion. 
• Incubate in ice for a few minutes (about 5 minutes). 
• Centrifuge at 5°C, 6240 x g for 5 minutes. 
• Filtrate the supernatant by using funnel and glass wool, put the filtrate in ice. 
• Setup the Qiagen tip 100. 
• Equilibrate a QIAGEN-tip 100 by applying 4 ml Buffer QBT, and allow the column to 
empty by gravity flow. 
• Apply the supernatant (filtrate) to the QIAGEN-tip and allow it to enter the resin by 
gravity flow. 
• Wash the QIAGEN-tip with 2 x 10 ml Buffer QC. 
• In a new 50 ml tube, elute DNA with 5 Buffer QF. 
• Precipitate DNA by adding 3.5 (0.7 volumes) room-temperature isopropanol to the 
eluted DNA. Mix and centrifuge immediately at 6240 x g, for 15 min at RT. Carefully 
decant the supernatant. 
• Wash the pellet with 2 ml of 70% ethanol, brief vortex. 
• Centrifuge immediately at 6240 x g (6000 rpm; Heraeus. Megafuge® 1.0R), for 10 
min at RT. 
• Discard the supernatant, brief centrifuging and pipette the rest of supernatant. 
• Air-dry the pellet, and dissolve the DNA in 500 µl ddH2O  
• Measure DNA concentration via nanodrop® ND-1000 Spectrophotometer. 
 
4.1.12.3- Endotoxin-free mini preparation of plasmid DNA from E. coli   
Plasmids with low endotoxin content, intended for transfection of eukaryotic cells, were 
prepared with the QIAGEN EndoFree plasmid buffer set (Qiagen; #19048) and QIAfilter 
plasmid midi kit (Qiagen; 12243, containing QIAGEN-tip 100 anion-exchange tips and 
QIAfilter Midi cartridges) were used for midi preparations. 
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Table 14: QIAGEN midi prep endotoxin free buffers 
Solution Name Compostition 
Plasmid solution I 
Endotoxin-free 
50mM Glucose, 10mM EDTA, 25mM Tris HCl buffer, pH 6-8 
Plasmid solution II 0,2M NaOH, 1% SDS 
Plasmid solution III 
Endotoxin-free 








750mM NaCl, 50 mM MOPS buffer, pH 7.0, 15% Isopropyl alcohol 
(v/v), 0.15 % Triton® X-100 (v/v)  
Buffer QC 
Wash buffer 
1.0 M NaCl, 50 mM MOPS, pH 7.0, 15% isopropyl alcohol (v/v)      
Buffer QN 
Elution buffer 
1.6 M NaCl, 50 mM MOPS, pH 7.0, 15 % isopropyl alcohol (v/v)     
 
• Inoculate 5µl of starter bacteria suspension in 50ml TY medium/antibiotic, incubate 
with shaking 200rpm at 37°C. 
• Harvest the bacterial cells by centrifugation at 2778 x g (4000 rpm; Heraeus. 
Megafuge® 1.0R) for 15 min at 4°C. 
• Re-suspend the bacterial pellet in 4 ml Buffer P1 by pipetting up and down until no 
cell clumps remain. 
• Add 4 ml Buffer P2, mix gently but thoroughly by inverting 4-6 times, and incubate at 
room temperature for 5 min.  
• During the incubation prepare the QIAfilter Cartridge: Screw the cap onto the outlet 
nozzle of the QIAfilter Midi Cartridge to prevent dripping. Place the QIAfilter 
Cartridge into a convenient tube. 
• Add 4 ml chilled Buffer P3 to the lysate, and mix immediately but gently by inverting 
4-6 times. Proceed directly to step 7. Do not incubate the lysate on ice. 
• Pour the lysate into the barrel of the QIAfilter Cartridge. Incubate at room temperature 
for 10 min. Do not insert the plunger. Do not agitate the QIAfilter Cartridge during 
this time 
• Remove the cap from the QIAfilter outlet nozzle. Gently insert the plunger into the 
QIAfilter Midi Cartridge and filter the cell lysate into a convenient tube. 
• Add 1ml (0.1 volumes) Buffer ER to the filtered lysate, mix by inverting the tube 
approximately 10 times, and incubate on ice for 30 min. 
• Equilibrate a QIAGEN-tip 100 by applying 4 ml Buffer QBT, and allow the column to 
empty by gravity flow. 
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• Apply the cleared lysate to the QIAGEN-tip and allow it to enter the resin by gravity 
flow. 
• Wash the QIAGEN-tip with 2 x 10 ml Buffer QC. 
• In new clean 50 ml tube elute DNA with 5 ml Buffer QN. 
• Precipitate DNA by adding 3.5 ml (0.7 volumes) of room-temperature isopropanol to 
the eluted DNA. Mix and centrifuge immediately at 6240 x g (6000 rpm; Heraeus. 
Megafuge® 1.0R) for 30 min at 4°C. Carefully decant the supernatant. 
• Wash DNA pellet with 2 ml of endotoxin-free room-temperature 70% ethanol and 
centrifuge at 6240 x g for 10 min at RT. 
• Air-dry the pellet, and redissolve the DNA in a suitable volume of endotoxin-free 
Buffer TE.  Do not dissolve with TE buffer, Dissolve with 250µl nuclease-free H2O  
• Measure the DNA amount via Nanodrop® ND-1000 Spectrophotometer.  
 
4.1.13- Cloning Strategies 
4.1.13.1- Plasmids for expression in eukaryotes 
PCR products were cloned blunt-end into cloning vector pKS (pBluescript II KS (+) GenBank 
X52327; Stratagene) and Sanger sequencing was used for verification of all PCR amplicons. 
The desired cassettes were inserted as XhoI/SalI fragments into the pM3 vector (Sadowski et 
al., 1992) restricted with SalI to generate a coding sequence for a fusion protein with the DNA 
binding domain of the yeast transcription factor GAL4 (GAL4-DBD) at its N-terminus. 
Correspondingly, eukaryotic expression vectors encoding fusion proteins with glutathione-S-
transferase from Schistosoma japonicum (GST) were generated by insertion of the XhoI/SalI 
fragments into pN2-GST (Born et al., 2014) digested with SalI (Fig. 6). The sequence 
encoding full-length ZNF777 (amino acids 1-831) was assembled in the pM3-ZNF777/1-362 
construct by inserting through the SacI site the respective fragment from a commercial 
truncated ZNF777 plasmid (BioCat GmbH/Heidelberg; # BC023985-seq-TCHS1003-GVO-
TRI, GenBank accession BC023985). The DNA sequence for full-length ZNF746a was 
purchased from BioCat GmbH/Heidelberg (BC068505-seq-TCHS1003-GVO-TRI). The 
coding sequences of mutant protein regions (Z746b/109-188_R141L, Z746b/109-188_G142E, 
Z746b/109-188_RG/LE, and Z746a/94-279-K189R) with flanking XhoI/SalI overhangs were 
purchased as in-vitro-synthesized DNA fragments that were cloned into the EcoRV site of the 
pUC57 vector (Eurogentec). XhoI-SalI fragments were subcloned into pExpr-IBA105 (IBA 
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GmbH #2-1905-000) digested with XhoI to generate a coding sequence of N-terminal One 
Strep-tagged proteins. 
To construct a coding sequence of a chimeric fusion protein between DUF3669 and the 
KRAB-AB domain of ZNF10, the coding sequences of DUF3669 domains of both ZNF777 
and ZNF746 without stop codon (Z746a/1-108 and Z777/189-254, respectively) were first 
cloned as XhoI/SalI fragment into pM3 restricted with SalI. Then the resulting plasmids were 
linearized with SalI and the coding sequence of the KRAB domain of ZNF10 as XhoI/SalI 
fragment was inserted in this site (Fig. 7). EcoRI/SalI DNA fragments for Z777/189-254 and 
Z777/1-282 were subcloned into pEGFP-C1 (Clontech #6081-1) restricted with EcoRI/SalI to 
generate a coding sequence for fusions with an N-terminal green fluorescent protein (GFP) 
fusions. To clone GST and GST-Z746a/1-279 into pcDNA5-FRT-TO expression vector 
(Invitrogen #V6520-20). The respective pN2-GST plasmid was restricted with HindIII/SalI 
restriction enzymes, and the resulting fragments were inserted into pcDNA5-FRT-TO plasmid 
restricted with HindIII/XhoI restriction enzymes.  
4.1.13.2- Plasmids for expression in prokaryotes  
For prokaryotic expression, the GST-Z746a/1-108 encoding BglII-SalI cassette was subcloned 
into bacterial expression vector pRSFDuet1 (Merck/Novagen #71341-3) restricted with BglII-
XhoI. To construct a coding sequence for maltose binding protein fusions (MBP), the SacI-
SalI fragments were subcloned into pMALc2x (New England Biolabs, addgene #75286) 
restricted with SacI-SalI. To generate 5xHis tagged proteins, XhoI/SalI fragments were 
subcloned into pRSET-B (Invitrogen # V351-20) restricted with XhoI. 




Fig. 6: Plasmid construction milestones. Exemplary plasmid construction milestones of pN2-GST-
ZNF777/283-362. Images depict ethidiumbromide-stained agarose gels. A: A blunt dsDNA PCR 
amplicon encoding ZNF777/283-362 with XhoI/SalI sites at its 5’ or 3’ end, respectively, was 
synthesized by RT-PCR using RNA derived from human testis as initial source (left image) and cloned 
blunt-end into cloning vector pBluescript KS linearized by EcoRV (right image). B: After 
transformation blue-white screening, plasmid mini preparation and analytical digestion with 
XhoI/SalI, clones containing the desired plasmid (here identified by the excision of a 249bp fragment) 
were identified by electrophoresis. C: Sanger DNA sequencing method was performed to verify the 
DNA sequences. D: XhoI-ZNF777/283-362-SalI was isolated from pKS vector by digestion with 
XhoI/SalI restriction enzymes followed by separation on agarose gel and purification. E: Subcloning 
into expression vector pN2-GST linearized with SalI. F: Minipreparation analysis to identify the 
sucloned colonies (subcloned vector gives 932bp fragment, and non-cloned vector gives 638bp 
fragment). G: Expansion of the subcloned colony followed by isolation of the subcloned plasmid using 
endotoxin-free midipreparation plasmid isolation method.   




Fig. 7: The workflow of construction of chimeric DUF3669-ZNF10AB encoding sequences 
(ZNF746a/1-108-ZNF10AB and ZNF777/189-254-ZNF10AB) in pM3 plasmid. pKS plasmid 
constructs with DUF3669 or ZNF10-AB sequences serve as donor plasmids. The desired fragment wer 
excised with XhoI and SalI restriction enzymes. DUF3669 was inserted into pM3 plasmid linearized 
with SalI. Then, the recombinant plasmid was restricted again with SalI and ZNF10AB was inserted at 
3’ end of DUF3669 resulting in a coding sequence of chimeric N-terminal DUF3669-ZNF10AB 
protein. 
Table 15: Plasmids that were used as either cloning or expression vectors 
Plasmid Description  
pKS pBluescript II KS(+) GenBank X52327 (Agilent/Stratagene # 212205) 
pM3 Dr. Lorenz, Immunology Rostock  (Sadowski et al., 1992) 
pN2-GST Dr. Lorenz, Immunology Rostock Modified from pEGFP-N2 
(Clontech #. 6081-1) (Born et al., 2014)  
pM3-ZNF10AB Dr. Lorenz, Immunology Rostock (Born et al., 2014) 
pN2-GST-ZNF10AB  Dr. Lorenz, Immunology Rostock  (Born et al., 2014) 
pExpr-IBA105 IBA GmbH # 2-1905-000_ 5471 bp 
pcDNA5-FRT-TO Invitrogen, #V6520-20 
pOG44 Invitrogen, #V6005-20 
pRSFDuet1 Merck/Novagen #71341-3; 3829bp 
pUC57Z746AB345  Eurogentec, Order 1000849727 
Project: U2844CI250-1 
pBR-ZNF 746 BioCat GmbH/Heidelberg (#BC068505-seq-TCHS1003-GVO-TRI). 
pOTB7-BC023985 BioCat GmbH/Heidelberg (# BC023985-seq-TCHS1003-GVO-TRI , 
Gene ID 27153) 
pUC57- 
Z746NT1a_K189R 
Eurogentec, Project: U9686DD110-1, Clone ID_M89815 
pGL3c-5'Gal5 (Born et al., 2014) 
pRLuc/TK Promega 
pEGFP-C1  Clontech #6081-1, 4737 bp 
pMal-c2X New England Biolabs. Add gene, #75286, 6645 bp 
pRSET-B Invitrogen # V351-20, 2900 bp  
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4.2- Cell Culture 
4.2.1- Cell lines and media  
All cell culture works were performed under a cell culture hood type II to maintain an aseptic 
work area (Herasafe™ KS). Media were pre-warmed immediately before use. 
Table 16: Cell lines and media used in this work 
Cell line  Origin source Medium 
HeLa human epitheloid cervix 
carcinoma cells 






Flp-In™ T-REx™ 293 293 human embryonic 
kidney cells 
(Graham et al., 1977) 
Thermo Fisher Scientific 
 #R78007 
HAP1 Wild type male chronic 
myelogenous leukemia 
(CML) cell line KBM-7 
Horizon Genomics 
#C631 
DMEM+GlutaMAX™   
Dulbecco's Modified 
Eagle Medium 
Gibco ®, #31966-021 
HAP1 TRIM28 ko Horizon Genomics  
# HZGHC000293c001 
HAP1 SETDB1 ko Horizon Genomics 
# HZGHC001331c001 
 
Media were supplemented with 10% inactivated fetal calf serum FCS (Biochrom FBS 
Superior, #S 0615), and 45 units/ml penicillin and 45 μg/ml streptomycin (Gibco®, #15070-
063). Flp-In™ T-REx™ 293 cells were in addition kept in the presence of 100µg/ml Zeocin 
(Invitrogen, #64-0509) and 15µg/ml Blasticidin (PAA Laboratories GmbH, #P11-017) 
4.2.2- Freezing and Thawing human Cell lines 
The cells were frozen in freezing medium (50%complete growth medium + 40%FBS + 10% 
DMSO) in liquid nitrogen. The cryovial containing the frozen cells was taken from liquid 
nitrogen storage and immediately placed into a 37°C water bath for ⁓1min. The cells were re-
suspended with 5ml pre-warmed complete growth medium in a 15 ml falcon tube and 
centrifuged at 210 x g (1100 rpm; Heraeus, Megafuge® 1.0) for 5min at room temperature. 
The supernatant was aspirated, and the pellet was re-suspended with 15ml pre-warmed 
complete growth medium, transferred to 250ml cell culture flask, and allowed to grow in a 
humidified atmosphere containing 5 % CO2 at 37 °C (BINDER).   
4.2.3- Cell passaging and seeding 
At confluency of maximally 90%, the medium was discarded and cells were briefly washed 
with 5 ml sterile 1x DPBS (Gibco, #14/90-094) and trypsinized with a 0.05 % Trypsin-EDTA 
solution (Gibco, # 25300-054) for ~5 minutes at 37 °C. When the cells were being suspended, 
5ml medium were added and the cell suspension was mixed thoroughly. The total number of 
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cells was determined using a hemocytometer (Neubauer Improved counting chamber, 
#T729.1). Appropriate volumes of cell suspensions were pipetted into new cell culture vessels 
and allowed to grow in the incubator. 
Table 17: Cell culture plastic wares 
24-Well Cell Culture Plate sterile, with lid Greiner bio-one, #662 166 
12-Well Cell Culture Plate sterile, with lid Greiner bio-one, #665180 
6-Well Cell Culture Plate sterile, with lid Greiner bio-one, #657 160 
6cm diameter cell culture dishes Greiner bio-one, #628 160 
10cm diameter cell culture dishes  Greiner bio-one, #633171 
CELLSTAR® Filter Cap Cell Culture Flasks, 75cm2, 250ml  Greiner bio-one, #658175 
CELLSTAR® Filter Cap Cell Culture Flasks, 25cm2, 50ml Greiner bio-one, #690175 
 
4.2.4- Transient transfection 
The lipid-based transfection method was used for all transfections. Commercial reagents that 
contain a proprietary blend of lipids and other components and supplied in 80% ethanol were 
applied according to manufacturer’s instructions. The cells were seeded in cell culture plates 
or dishes and maintained until reaching the desired cell confluency. All transfections were 
conducted at about 70-90% cell confluency. For dual luciferase assay; HAP1 wild type and 
knockout cells were transfected using TurboFectin 8.0 reagent (OriGene, #TF81001), whereas 
HeLa cells were transfected using X-tremeGENE 9 (Roche, #06365787001). For 
immunoprecipitation and affinity pull-down assays, HeLa cells and Flp-In™ T-REx™ 293 
cells were transfected with FuGENE® HD (Promega, E2311). The media were changed just 
prior to transfection. Transfection complexes were formed at 3µl transfection reagent per 1 µg 
DNA in Opti-MEM® I medium (Gibco, #51985026) during a 15-20min incubation at room 
temperature and added then to the cells dropwise. The dishes and the plates were then gently 
rocked back and forth and from side to side to ensure thorough mixing. 
4.2.5- Generation of stable cell lines 
The Flp-In T-Rex 293 cell line  (short FITR293) was used for the generation of isogenic lines 
that inducibly and stably overexpress the gene of interest (Karimi et al., 2007). Flp-In T-Rex 
293 cells contain an integrated FRT (Flp recombination target) locus known to be permissive 
for robust transcription. This locus expresses a lacZ-zeocin fusion as a marker. Further, the 
cells stably express a Tet-OFF Tet repressor protein under the control of the human CMV 
promoter and blasticidin as a selection marker. The recombination into the target locus is 
accomplished by using two plasmids. Plasmid pcDNA5/FRT/TO (Invitrogen, #V6520-20) 
plasmid contains the gene of interest under the control of a CMV/TetO2 promoter and the 
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hygromycin resistance gene with an FRT site embedded in the 5′ coding region. The 
hygromycin resistance gene does not have a promoter and the ATG startcodon. Vector 
pOG44 (Invitrogen, #V6005-20) constitutively expresses the Flp recombinase under the 
control of the human CMV promoter. Incorporation of pcDNA5/FRT/TO into FRT site of the 
genome makes the SV40 promoter and the ATG start codon (from pFRT/lacZeo) near and 
frame with the hygromycin resistance gene, and at the same time disrupts the lacZ-Zeocin 
fusion gene. Thus, stable Flp-In T-REx expression cell lines can be characterized for the 
following phenotypes; Blasticidin resistance, Hygromycin resistance, Zeocin sensitivity, and 
Lack of β-galactosidase activity 
Flp-In T-Rex 293 cells were grown in 6cm dishes under the following selective medium; 
[(DMEM) supplemented with 10 % fetal calf serum (FCS) (Biochrom FBS Superior S 0615), 
100 units/ml penicillin and 45μg/ml streptomycin (Gibco®, #15070-063) + 45µg/ml Zeocin 
(Invitrogen #64-0509) + 15µg/ml Blasticidin (PAA laboratories GmbH_ #P11-017)].  
Directly before transfection, the selective medium was replaced with a new selective medium 
that lacks Zeocin. Cells within each dish were co-transfected with either pcDNA5-FRT-TO-
GST or pcDNA5-FRT-TO-ZNF746a/1-279 (expresses Hygromycin B resistance and 
respective GST fusion protein), and with pOG44 (expresses Flp recombinase). The total 
amount of DNA is 5µg), 3µl/1µg DNA of transfection reagent was deployed (FuGENE® 
HD). 
24h post-transfection, the cells were transferred from 6cm dish to 10 cm dish (Greiner bio-
one, #633171) (each in 2x 10cm dishes). 48 h later, the medium was replaced with second 
selective medium that is composed of; [DMEM+10% FCS + 45 units/ml penicillin+45 μg/ml 
streptomycin] + 15µg/ml Blasticidin + 250µg/ml Hygromycin B. Two weeks later, the visible 
foci were picked and grown in 24 cell culture well plates under the condition of the selective 
medium that contains 250µg/ml Hygromycin B. Colonies were screened for expression of the 
desired protein by indirect immunofluorescence and Western blotting (Fig: 13). The 
expression of the transgene was induced by 2µg/ml tetracycline for 24 hours before analysis. 
The positive colonies were expanded in 75cm2 cell culture flasks. The cells were trypsinized 
and counted. Then, 1 million cells were re-suspended in 1 ml freezing medium (50% growth 
medium + 40%FBS + 10% DMSO) and put in 1 ml cryogenic vials and stored at -70 ºC for 
few days. Vials were transferred to the liquid nitrogen tank (-180 ºC) for long-term storage. 
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4.3- Production of recombinant proteins in E. coli 
E. coli strain BL21 (DE3) contains the λDE3 lysogen that contains T7 RNA polymerase gene 
under the control of the lacUV5 promoter. Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
induces the expression of the T7 RNA polymerase that enhances the overexpression of the 
recombinant genes cloned downstream of a T7 promoter. 
This strain is deficient in Lon protease (cytoplasm) and OmpT protease (outer membrane), 
resulting in a higher yield of intact recombinant proteins. 
Genotype: fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS  
λ DE3 = λ sBamHIo ∆EcoRI-B int (lacI PlacUV5 T7 gene1) i21 ∆nin5 
Here, an optimized commercial strain, SoluBL21, that has undisclosed mutations after 
screening for higher solubility of recombinant proteins, was used and obtained as competent 
bacterial stock (Amsbio # C700200). Transformation proceeded with 10ng of 5xHis tagged 
protein expression vector (pRSET-B-Z746a/1-108, pRSET-B-Z777/189-254, and pRSET-B-
Z777/1-282), GST (pGEX6P-1), GST-Z746a/1-108 (pRSFDuet1-GST-Z746a/1-108), MBP 
(pMalc2x) and MBP-Z777/189-254 (pMalc2x-777/189-254). 49µl of competent bacteria were 
mixed with an equivalent volume of 10ng plasmid, the heat-pulse of the mixture was 
conducted at 42° C for 45 seconds, and then 250µl of TY (Tryptone Yeast) medium were 
added to the mixtures, and incubated for 1h at 37°C with shaking. The transformation 
mixtures were plated onto a 10 cm LB (lysogeny broth) agar plate using a metal loop, which 
was flamed beforehand. The plates were incubated upside down overnight at 37°C.  
For the starter culture, a single colony was picked from each plate and incubated in 2ml of 
glucose-rich growth medium (RMG) supplemented with an appropriate antibiotic at 37°C 
overnight with shaking 200rpm. For expansion, 50µl of the overnight culture were diluted in 
5ml of fresh RMG medium and cultured under the same conditions until reaching 
OD600 nm≈0.5. The bacteria were pelleted by centrifuging for 10min at 2777x g (4000 rpm; 
Heraeus. Megafuge® 1.0R) at 4°C; washed with 5ml PBS and re-suspended in 5 ml SB-
medium with an appropriate antibiotic. 
Expression was induced by adding 0.1mM IPTG (5 µl of 0.1M IPTG stock = 23.8 mg/ml in 
H2O) to SB bacterial suspension and the bacterial mixture was incubated with shaking for 4h 
at 37 °C. The bacteria were then pelleted by centrifuging for 10min at 2777x g (4000 rpm; 
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Heraeus. Megafuge® 1.0R), 4°C, the pellets were washed with 5ml of 50mM TRIS/HCl 
(PH:8), 300mM NaCl.  
The bacteria were re-suspended with buffer lysis buffer (Table 22). Cells were lysed by four 
15-second sonication cycles. The lysates were cleared by centrifugation for 30min at 16060 x 
g (13 000rpm; Heraeus fresco biofuge) at 4°C. The expression levels and quality of the 
different recombinant proteins in these crude extracts were analyzed by Western blotting (Fig. 
14) and served as input for pull-down assays. shows western blot results of fusion proteins 
after probing with respective antibodies. 
Table 18: Media used for in vitro translation 
Medium Composition 
RMG for 1 liter: 10 g Tryptone, 5 g yeast extract, 5 g NaCl, 2 g Glucose 
SB component A for 1L: 12 g peptone from casein, 24g yeast extract, 4ml glycerol, 
component B for 1L: 340 mM KH2PO4, 1.44M K2HPO4; ready-to-use medium: 950ml 
component A+50ml B 
4.4- Immunofluorescence 
Indirect immunofluorescence staining was used to control for expression of a construct and 
for qualifying the intracellular distribution of the encoded protein. 
Table 19: Immunofluorescence solutions 
Solution Composition 
PAFA fixative 1xPBS, 4% (w/v) paraformaldehyde, pH=7.3 
Permeabilization buffer 1x PBS, 0.5% (w/v) Triton X-100 
Antibody buffer 1x PBS, 1% (v/v) Normal goat serum, 1% (w/v) BSA 
DAPI staining buffer 1x PBS, 0,5µg/ml DAPI 
PBS 137mM NaCl, 12mM Phosphate, 2.7mM KCl, pH=7.4 
Mounting medium 90% (v/v) glycerol, 10% (v/v) PBS, 0.1% (w/v) p-phenylenediamine, 
adjusted with 0.1M carbonate bicarbonate buffer to pH=8.5 
Carbonate-bicarbonate buffer 184mM Na2CO3, 16mM NaHCO3 
 
The coverslips (20 x 20 mm) were flamed and placed into cell culture wells. If Flp-In T-REx 
293 cells were used, the coverslips were coated with poly-L-lysine (SIGMA, #25988-63-0, 
0.01% solution) as follows: 
• Place a drop of poly-L-lysine on each coverslip and leave for 15min. 
• Aspirate off the poly-L- lysine and rinse the coverslips 2x with PBS.  
• Aspirate off the PBS and let the coverslips dry for 1-2 h.  
The cells were grown on glass coverslips placed in 6-well cell culture plates. The transfection 
or expression induction was conducted when the cells reached approximately 70-90% of 
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confluency. 24h post-transfection, the medium was aspirated and the cells were rinsed briefly 
with cold 1x PBS, fixed by incubating the cells with 2ml PBS (4%/w/v) paraformaldehyde for 
15 min at RT without shaking, and permeabilized by incubating cells in 1ml PBS, 0.5% (w/v) 
Triton X-100 for 5 min at RT. 
The cells' sides of coverslips were incubated with 45µl of primary antibody solution for 
30min at RT (Table 20). The coverslips were then rinsed briefly with PBS, washed 3x 5min 
with PBS, and incubated with 45µl secondary antibodies solution for 30min at RT. Then the 
coverslips were rinsed and washed 1x 5min with PBS. The nuclei were stained with 2 ml 4′,6-
diamidino-2-phenylindole (DAPI) for 5min and washed with PBS 1x 5 min. The cell side 
coverslips on object slide were mounted in mounting medium and sealed with nail polish. The 
slides were stored at -20°C. 
Images were acquired with a confocal microscope (Leica TCS2 AOBS) using a 63× oil 
immersion lens (numerical aperture of 1.32) or Zeiss LSM 780 Confocal Microscope with the 
PlanApochromat 63x/1.40 Oil DIC M27 objective. Image Studio Lite 5.2 and ZEISS ZEN 
Imaging Softwares were used for image processing.  
Table 20: Primary and secondary antibodies used for immunofluorescence staining 
Antibody Stock concentration Dilution  
Rabbit anti-GAL4 
 (Santa Cruz, # sc-577) 
200µg/ml 1:100 
Monoclonal antibody anti TIF1beta/KRIP-1 (BD 
610680/K57620) 
250µg/ml 1:200 
Rabbit anti TRIM28/TIF1-beta  
(Santa Cruz, # sc-33186) 
200µg/ml 1:50 
Monoclonal mouse anti GST  
(Abcam, #ab92) 
1mg/ml 1:100 
Rabbit anti GST  
(Santa Cruz, #sc-459) 
200µg/ml 1:200 
Goat anti-rabbit-IgG-fp488  
(Interchim Fluoprobes,  #FP-GARBTTGY488) 
0.5mg/ml 1:400 
Goat anti-mouse-IgG-Alexa633  
(Life Technologies, #A-21052) 
2mg/ml 1:200 
Goat anti-rabbit-IgG-fp642  
(Interchim Fluoprobes, #FP-GARBTTGY642) 
0.5 mg/ml 1:200 
Goat anti mouse-IgG-Alexa488 
(Thermo Fisher,  #A-11029) 
2mg/ml 1:400 
4.5- Immunoprecipitation and Pulldown Assays 
4.5.1-  Lysis of eukaryotic cells 
Testing for the presence of the presumable protein interaction partners in the same protein 
complex was done using co-immunoprecipitation or affinity pull-down assays based on 
ligands for the tags of the interrogated proteins after transfection of respective constructs. The 
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scale for co-immunoprecipitation was usually 0.5-1 million cells per 6-cm dish grown for 2 
days, transfected with a total amount of 5µg expression vector(s) and harvested 24 hours post-
transfection. Affinity pull-down assays used the same scale or single wells of 6-well plates 
transfected with a total of 2.5µg DNA. The media were aspirated and the cells were briefly 
rinsed with ice-cold 1x PBS and washed with 3ml 1 x TST2 buffer. The cells were incubated 
with 1.5 ml TST2 complete for 5 min on ice. The cells were then scraped with a cell scraper 
(TPP Cell scraper 30cm, 99003). The raw extracts were transferred into 2ml reaction tube, 
vortexed, and the extracts were sheared through QiaShredder columns (Qiagen, #79656) and 
centrifuged for 5 min at 4°C/16060 x g (13000rpm, Heraeus Biofuge Fresco). The 
flowthrough extracts were centrifuged (⁓1500 µl) for 10min at 16060 x g, 4°C. The 
supernatants were transferred into a fresh tube. 
4.5.2- Immunopreciptation and pulldown assays in eukaryotic cells 
All buffers and tubes were ice cold before use. The beads were prepared by aspirating the 
storage buffer and washing the beads with TST2 buffer, for each sample appropriate amount 
of beads were pipetted into 1.5ml tube (Table 22).  
For immunoprecipitation, the beads were suspended in 25µl TST2 complete + 1µl antibodies 
against TRIM28; (roughly 1mg/ml concentration; mAb 1Tb1A9, (Remboutsika et al., 1999); 
a kind gift of Pierre Chambon and Régine Losson; Illkirch, France). The tubes were incubated 
at RT with shaking for 30min. 
1000µl of crude cell extracts were mixed to beads/beads loaded with antibodies and incubated 
overnight with end-over-end mixing at 4° C, 500 µl of extract for each sample were stored at -
20°C. The beads were washed with 3 x 0.5 ml each with TST2+0.5% TritonX-100. The beads 
were then washed again with 1 ml with TST2. The beads were eluted with respective elution 
buffer. The eluates and the whole-cell extracts (TST2 extract) were tested on 12% SDS-
polyacrylamide gel electrophoresis and Western blotting. 
4.5.3- Pulldown assay with NiNTA agarose beads 
An appropriate aliquot (70 -200 µl) of a 5xHis-tagged recombinant protein extract was 
combined in vitro with an aliquot of another extract containing GST- and MBP fusion 
proteins (40 - 75 µl) in different combinations and mixed with 20µl Ni-NTA magnetic bead 
suspension in extract buffer. After overnight incubation at 4°C on a rotating mixer, the beads 
were washed 5 x 5 min with wash buffer (Table 22) followed by washing for 3 x 5min with 
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the same buffer without BSA. The proteins were eluted and the eluted proteins were separated 
on 18% SDS-PAGE gel. 




Protein G Mag-Sepharose Beads  
GE Healthcare,  #28-9440-08) 
25µl/sample 30µl 1x SDS sample buffer 
(Table 23) 
Strep Tactin-Superflow  
IBA GmbH, #2-1206-010 
50µl/sample 40µl 3mM D (+)-Biotin in TST2 
 Carl Roth GmbH #3822.1 
Glutathione Magnetic Agarose 
Beads 
Pierce, #78601 
50µl/sample 40µl 50mM reduced Glutathione in TST2 
Sigma-Aldrich #G4251-1G  
Ni-NTA magnetic bead 
Qiagen, #36111 
20µl/sample 250mM imidazole in 50mM TRIS/HCL, 
300mM NaCl (PH:8) 
 
Table 22: Buffers used for immunoprecipitation and pulldown assays 
Buffer  Composition 
TST2 20 mM TRIS/HCl pH7.5; 60 mM KCl, 15 mM NaCl, 10 mM MgCl2, 1mM CaCl2, 
250 mM Sucrose 
TST2 complete TST2 buffer, 0.5% Triton X-100, cOmplete ULTRA Tab. Mini EDTA free 
(Roche,#0589279100),1mM DTT, 1 mM Na3VO4, 50 mM NaF, 40 mM beta- 
Glycerophosphate.   
Lysis buffer of 
prokaryotic cells  
50mM TRIS/HCl (PH:8), 300mM NaCl, protease inhibitor (cOmplete ULTRA 
Mini EDTA free, Roche_ # 05 892 970 001, 1tablet/10ml ), 20% glycerol, 0.1% 
bovine serum albumin (BSA), 20mM imidazole, and 0.05% tween 20 
Wash buffer for 
NiNTA beads 
50mM TRIS/HCl (PH:8), 300mM NaCl, 0.1% bovine serum albumin, 20mM 
Imidazole and 0.05% Tween20 
  
4.6- SDS-PAGE (sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis) 
One dimensional gel electrophoresis under denaturing conditions in the presence of 0.1% SDS 
was performed to test for protein expression and co-associated proteins. The gel is cast as 
separating denaturing sodium dodecyl sulfate-polyacrylamide gel (10%-18%) and topped by 
~0.5-1cm of 4.5% staking sodium dodecyl sulfate-polyacrylamide gel. The proteins were 
denatured and solubilized by heating in the SDS loading buffer at 95°C for 5min.  
Samples preparation:  
For expression test, 24h post transfected cells were extracted with sodium dodecyl sulfate 
(SDS). The extracts were sheared through QiaShredder columns (Qiagen, 79656) and 
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centrifuged for 5 min at 16 060 x g (13 000rpm) at 4°C. SDS samples were denatured by 
heating 5min at 95°C. For purified proteins, the eluates were diluted with SDS loading buffer 
and denatured by heating 5min at 95°C. SDS samples were loaded into sodium dodecyl 
sulfate-polyacrylamide gel and the electrophoresis run was performed at constant 30 mA. 
Electrophoresis was stopped once the downmost sign of the protein marker almost reaches the 
foot line of the glass plate. 
Table 23: SDS-PAGE buffers and solutions 
Solution Composition 
Tris/HCl buffer pH=8.9  1M Tris/HCl 
Tris/HCl buffer pH=6.8 1M Tris/HCl 
Acrylamide / Methylenbisacrylamide (BisAA) 
(Roth Rotiphorese Gel 30, #3029.1) 
30%/0,8% (v/v) 
Laemmli SDS-Sample Buffer 5x 312.5mM TRIS/HCl, 10% SDS, 325mM DTT, 
0.08 Bromophenol blue, 50% Glycerin.pH=6.8 
Tetramethylethylendiamine (TEMED) , Serva, #35930 99.0% 
Ammonium persulfate (APS) Serva, #13375.03 10 % (w/v) in H2O, freshly prepared 
Running buffer  0.25M TRIS BASE, 1%SDS, 1.92M Glycine 
 
Table 24: SDS- polyacrylamide gel composition 











AA/BisAA  7ml 8ml 10ml 12ml  1.5ml 
Tris/HCl buffer 
pH=8,9 
8 ml 8ml 8ml 8ml  --- 
Tris/HCl buffer 
pH=6,8 
--- --- ---- --- 1.25ml 
H2O 5 ml 4ml 2ml --- 7ml 
10% SDS 216 µl 216µl 216µl 216µl 100µl 
10% APS 160µl 160lµl 160lµl 160µl 100µl 
TEMED 20 µl 20µl 20µl 20µl 10µl 
4.7- Western blotting 
Electroblotting of separated proteins from polyacrylamide gels on membranes 
Semi-dry Western blotting was performed according to the method of Kyhse-Anderson 
(Kyhse-Andersen, 1984). 
After electrophoresis, the separated proteins were electroblotted onto low-fluorescence 
polyvinylidene difluoride (PVDF) membrane (Immobilon®-FL, #IPFL00010). To allow the 
migrated protein to transfer from the gel to PVDF membrane, several layers of humidified 
absorbent filter papers were used.  
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18 filter papers and PVDF membrane were cut to the dimension of the SDS/PAGE gel, and 
they were assembled in a transfer cell as follows: 
• 6x filter papers were saturated with HT and placed onto the platinum anode. 
• 3x filter papers were saturated with LT.  
• Equilibrated PVDF membrane (wetted with isopropanol, rinsed with dH2O, and 
 wetted with LT buffer). 
• Equilibrated SDS gel (by ε-aminocaproic acid buffer). 
• 9x filter papers were saturated with a ε-aminocaproic acid buffer 
• Stainless cathode  
• After each step, roll out the air bubbles. 
• The transfer cell was run at 25V for 2h (Bio-Rad Trans-Blot SD Semi-Dry Transfer              
Cell). 
Transfer efficiency was checked by reversibly staining with Ponceau S dye (0.3 % Ponceau S 
in 3 % TCA), the membrane was then rinsed gently with dH2O water. An image was taken 
for Ponceau stained membrane. 
The membrane was wetted again with isopropanol and rinsed with PBS. Non-specific antigen 
binding was blocked by Odyssey blocking buffer (LI-COR, #927-40000) at 4°C overnight. 
Transfer unit: Bio Rad Trans-Blot SD Semi-Dry Transfer Cell 
Table 25: western blot solutions 
Solution Composition 
ε-aminocapric acid buffer 0.04M ε-aminocapric acid, 0.025M TRIS base 
20% Methanol, pH = 9.4 
HT buffer 0.3M TRIS base, 20% Methanol, pH = 10.4 
LT buffer 0.025M TRIS base, 20% Methanol, pH = 10.4 
Ponceau S solution 0.3% Ponceau S (w/v), 3% Trichloro acetic acid 
PBS 137mM NaCl, 12mM Phosphate, 2.7mM KCl, pH = 7.4 
 
The probing of the transferred proteins with relevant antibodies was done as follows: The blot 
was incubated with antibodies solution for 2h. at RT with gentle shaking. Afterward, the blot 
was washed 4x5min with wash buffer and incubated with secondary antibodies solution for 1h 
at RT with shaking. The membrane was washed again 4x5min and rinsed with PBS. The 
membrane was stored in PBS, and protected from light until scanning. Primary antibodies 
were detected by fluorescently-tagged secondary antibodies against rabbit or mouse IgG (LI-
COR # 926-32211, # 926-32220) and signals were acquired using an LI-COR Odyssey® CLx 
imager. The indicated image panels in figures were always subjected “in one piece” 
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simultaneously to any contrast or brightness adjustment within the LI-COR Image Studio Lite 
5.2 software before export as black-and-white or pseudo-color image files. 
Table 26: Buffers for staining with antibodies 
Blocking buffer  Odyssey® Blocking buffer (LI-COR # 927-40000) 1:2 diluted with 
filtrated 1x PBS 
Wash buffer 1x filtrated PBS supplemented with 0.1 % Tween 20 
Antibodies dilution buffer Odyssey® Blocking buffer (LI-COR # 927-40000) 1:2 diluted with 
filtrated 1x PBS supplemented with 0.1 % Tween 20 
 
Table 27: Primary and secondary antibodies used for detection of the blotted proteins 
Antibody Stock concentration Dilution  
Rabbit anti-GAL4 (Santa Cruz, #sc-577) 200µg/ml 1:1000 
Rabbit anti-GST (Santa Cruz, #sc-459) 200µg/ml 1:1000 
Monoclonal antibody anti-GAPDH  
(Abcam, #ab8245) 
500µg/ml 1:5000 
Rabbit anti TRIM28/TIF1-beta  
(Epitomics, #3509-1) 
not specified  1:2000 
Monoclonal anti-One II (IBA, #2-1507-001) 100µg 1:1000 
Monoclonal antibody anti-TRIM28 (BD Bioscience, 
#K57620/610681) 
250µg/ml 1:1000 
Rabbit anti MBP (Santa Cruz, #No.sc-808) 200µg/ml 1:2000 
Mab anti GFP, (Santa Cruz, #sc-808). 400µg/ml 1: 1000 
Monoclonal Penta His antibody, BSA free 
 (Qiagen, #34660)  
0.2mg/ml 1:1000 
Goat anti-mouse-IgG-IRDye 680CW 
(Li-COR, #926-68070  
1mg/ml 1:10 000 
Goat anti-rabbit-IgG-IRDye 800CW 
(Li-COR, #926-32211) 
1mg/ml 1:10 000 
 
4.8-  Dual-luciferase reporter assay 
Dual-luciferase reporter assay is a heterologous reporter assay, in which the expression of the 
luciferase reporter gene is regulated by the GAL4-DBD fusion protein. Firefly luciferase 
(Photinus pyralis) reporter expressing vector pGL3control-(5’Gal4)5 (referred as pGL3c-
5´Gal5 is derived from pGL3control (Promega, #E1741) and modified by inserting five DNA-
binding sites for the Gal4 DBD at the BglII/HindIII restriction site upstream of a strong SV40 
promoter (Born et al., 2014). In addition to firefly luciferase plasmid (pGL3c-5´Gal5), the 
cells were transfected with Renilla luciferase-expressing gene pGL 4.74 (hRluc/TK, Promega 
#E692A) which lacks GAL4-DBD DNA binding site was used for normalizing. Both 
luciferase reporter plasmids were transfected together with effector plasmid (expresses either 
GAL4 alone or GAL4 fusion protein). Three independent experiments at least with duplicates 
within each experiment were performed for each effector plasmid. Promega’s Dual-Luciferase 
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Reporter Assay System (Promega, #E1910) was used to perform dual-luciferase assays in 
accordance with the manufacturer's instructions. 
Cells were seeded in 6-well cell culture plates as follows; 2.5x105 cells/well for HeLa, 3x105 
cells/well for HAP1 wild type and HAP1-SETDB1 knockout cells, and 6x105 cells/well for 
HAP1-TRIM28 knockout cells. The cells were incubated for 48h until reaching 70-90% 
confluency and transfected with; 750ng effector plasmid, 250ng pGL3c-5´Gal5, and 10ng 
pGL 4.74 (hRluc/TK). 
The medium was discarded, and the cells were briefly washed with 1x PBS and lysed by 
incubating with 500µl passive lysis buffer (supplied in the kit) on a shaker for 15min at RT. 
The lysates were then collected in 1.5ml tubes and centrifuged for 5min at RT/ 16060 x g 
(13000 rpm; Heraeus Biofuge fresco).  
The activities of firefly and Renilla luciferases of each sample were sequentially measured 
after all samples were ready using single-tube measurements in Berthold single-channel 
luminometer (Lumat LB9501) as follows: Firefly luciferase measurements were started by 
adding 20 µl of the cell lysate to 100µl Luciferase Reagent II in luminometer plastic tube. The 
tube was immediately placed into the luminometer and measurements were carried out for 10 
sec. Then, 100 µl of Stop & Glow® reagent were added to stop the luciferase activity and 
catalyze the Renilla reaction, and then Renilla activity was measured for 10 sec. Firefly 
luciferase activities were normalized with respective Renilla luciferase activities for each 
biological sample. The luciferase activity in the presence of the effector plasmid expressing 
the GAL4 DNA binding domain alone represents the reference transcriptional capacity. Fold 
repression was calculated experiment-wise by dividing the normalized luciferase activity of 
that reference through normalized luciferase activities of the sample with the respective test 
effector plasmid. 
4.9- Compilation of DUF3669-containing KRAB-ZNFs 
According to the InterPro database, the human genome encodes six KRAB-ZNF proteins with 
the “domain of unknown function 3669” (DUF3669) at their amino termini 
(http://www.ebi.ac.uk/interpro/entry/IPR022137/proteins-matched). First, we compiled all 
orthologs of the six human DUF3669-containing proteins from the TreeFam database release 
9. 207 DUF3669-containing proteins were identified, all of them are ZNF proteins and can be 
categorized into six major orthologous protein groups, ZNF212, ZNF282, ZNF398, ZNF746, 
ZNF777, and ZNF783. 
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For each identified protein we then extracted the DUF3669-containing polypeptides including 
all other residues encoded by the same single exon from Ensembl Release 95 (January 2019). 
We then employed multiple alignments (https://www.genome.jp/tools-bin/clustalw) followed 
by using profile Hidden Markov Model (HMM) software (HMMbuild of HMMER version 
2.3.1; installed on a local server) to generate profile consensus sequence matrices for 
DUF3669 (hmm file). Using the protein BLAST server of NCBI and Uniprot 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi and https://www.uniprot.org/blast/) with default 
parameters, we searched for more DUF3669-containing proteins in the animal phyla. 
DUF3669-containing proteins were trimmed according to HMMER result to retrieve 
DUF3669 sequences. The total number of DUF3669-containing proteins tested in this study 
was 505. Finally, ClustalW alignments of the conserved sequences were used as input to 
generate sequence logo representations for the DUF3669 sequences 






The canonical function of the KRAB-ZNF proteins is the transcriptional repression. However, 
transcriptional repression activities of only a limited number of KRAB-ZNF proteins have 
been investigated in detail so far. Both, ZNF746 and ZNF777 are evolutionarily conserved 
proteins (Liu et al., 2014) and conform to the canonical structure of the KRAB-containing 
zinc finger protein family regarding the presence of an amino-terminal KRAB domain 
followed by a tandem array of contiguous zinc finger motifs. However, they display an 
additional exceptional feature, the domain of unknown function DUF3669 at their far amino 
termini. As indicated by its acronym, the function of DUF3669 is largely unknown. 
5.1- Six human KRAB-ZNFs have an extremely 
evolutionarily conserved DUF3669 and specific to amniotes 
A new domain model that was based on the DUF3669 sequences of the six human members 
and their orthologs in other species was generated. As described in the method section, all 
orthologs were compiled using public database resources and reciprocal BLAST searches, see 
additional file 1 in  Al Chiblak et al., 2019. Interestingly, the DUF3669 domains are only 
found in the genomes of amniotes, but not in amphibians (Table 28). 
































































Mammalia 48 62 33 59 1 64 33 26 326 
Reptilia 1 10 0 0 0 7 0 61 79 
Aves 0 27 0 0 0 19 0 55 101 
Amphibia 0 0 0 0 0 0 0 0 0 
Sum 49 99 33 59 1 90 33 142 506 
no. of DUF3669 49 99 31 59 1 90 33 176 538 
no. of KRAB-A 49 99 33 58 0 90 33 162 524 
no. of KRAB-B 4 60 1 58 0 88 31 119 361 
no. of proteins with ZnF 
(at least 1) 
48 79 33 54 0 87 24 97 422 
 
An overall consensus DUF3669 domain logo, as well as individual ortholog group logos were 




that has several absolute conserved amino acids in all compiled proteins and might be a 
consensus of DUF3669 which is longer than that of PF12417.  
As described for the DUF3669 domain (Fig. 7), an overall consensus KRAB-A logo as well 
as consensus logos for the individual orthologous groups were generated. The KRAB-A 
subdomain of ZNF10 was used as a standard KRAB-A subdomain (Fig. 9). Several previous 
studies demonstrated that MLE motif in the canonical KRAB-A subdomain plays an essential 
role in the interaction with TRIM28 and thereby the repressive activity ( Margolin et al., 1994; 
Witzgall et al., 1994; Friedman et al., 1996; Peng et al., 2009; Murphy et al., 2016). Of note, 
all human DUF3669-containing zinc finger proteins and their orthologs lack this canonical 
MLE motif in their KRAB-A subdomain. Instead, they often display amino acid stretches like 
“MKG”, “MRG”, and “VKE”. This suggests that the KRAB domain of DUF3669-containing 
KRAB-ZNFs might not be able to form stable complexes with TRIM28 as well as show 
different behavior with respect to transcriptional regulation compared to canonical KRAB 
domains.  
 
Fig. 8: Compilation of amino acid sequence logos for DUF3669 domain-encoding genes from 
mammals, birds, and reptiles. The logos were generated with WebLogo 3.7.0 
(http://weblogo.threeplusone.com/). The x-axis indicates the position within the domain and the y-axis 
denotes the information content (bits) for each amino acid. The height represents the frequency of 
each amino acid at a certain position within the tested sequence set. The overall DUF3669 consensus 
sequence at the top was derived from 505 DUF3669-containing proteins from amniotes. The other 
DUF3669 domain logos represent the ortholog groups of the six DUF3669-encoding KRAB-ZNFs 
(ZNF212 n=49; ZNF282 n=99; ZNF398 n=33; ZNF746 n=59; ZNF777 n=90; ZNF783 n=33). 





Orthologs of the human DUF3669-containing proteins were only found in amniote species 
from reptiles and birds to mammals, but not in amphibians. Sauropsids were thus the 
evolutionary oldest taxa encoding DUF3669 sequences according to our definition (Al 
Chiblak et al., 2019, additional file 1). Although named ZNF767, the seventh gene potentially 
gives only rise to a protein just consisting of DUF3669 without any other known domain. In 
public databases, ZNF767 is considered to be a pseudogene.  
Interestingly, ZNF746 and ZNF212 orthologs were not detected outside mammals, whereas 
the others were found in mammals, birds, and reptiles. This suggests that ZNF746 and 
ZNF212 emerged more recently than other DUF3669-containing KRAB-ZNFs. Most ZNF746 
orthologous proteins contain truncated KRAB-A subdomain at their amino termini. In 
addition, the amino acids in zinc finger motifs of the six human DUF3669-containing proteins 
that have the major impact on DNA binding specificity “recognition code” are clearly specific, 
this suggests that these proteins recognize different endogenous genomic targets and execute 





Fig. 9: Amino acid sequence logos for KRAB-A boxes in 505 DUF3669-containing zinc finger 
proteins and in each orthologous group as in Fig. 8. The highlighted amino acids represent the 
position of amino acids thought to be essential for the interaction with TRIM28 and repressive 
activities (DV and MLE). The amino acid sequence of the KRAB-A subdomain of ZNF10 is used for 
comparison (on the top). 
5.2- Protein constructs and expression verification  
A number of dedicated expression vectors were constructed to investigate the contribution of 
the KRAB and DUF3669 domains of ZNF746 and ZNF777 to transcriptional modulation and 
to study the formation of protein complexes. The expressed protein fragments contain KRAB 
domains, DUF3669 domains, zinc finger motifs, and combinations of them (Fig. 10) were 




ZNF746 (PARIS, given name: ZNF746a_UniProtKB: Q6NUN9) has a KRAB-A subdomain 
that is 15 amino acids truncated at its amino terminus as compared to the human KRAB-A 
consensus (Supplement S1). However, sequence databases contain information on another 
isoform that has a complete KRAB-A. This isoform was designated ZNF746b and is 
represented by UniProtKB database entry A0A2R8YDQ5 (Fig. 16). The existence of this 
isoform was confirmed by cloning the respective constructs from an initial ZNF746 amplicon 
obtained by RT-PCR from the human fetal brain and human testis RNA. We compensated for 
the truncated region of the KRAB-A box in ZNF746a by adding 15aa from the adjacent 
amino-terminal part (Z746a/94-173) to get a relatively similar protein size to its counterpart of 
ZNF746b isoform. 
 
Fig. 10: Schematic representations of the primary protein structures encoded by the various 
constructs employed in this study. Shown are the full-length proteins and the truncated versions along 
with the names of the constructs/protein pieces used throughout the manuscript. The different protein 
segments were expressed as fusion proteins with various partners depending on the experimental 
approach and indicated in the respective figure legends. Each curved round corner box denotes the 
protein region encoded by a separated exon. The numbers correspond to the amino-acids positions in 
the respective full-length protein. The known protein domains are labeled, i.e. DUF3669 (DUF, 
yellow), KRAB-A (“A”, red), KRAB-B (“B”, blue), C2H2 zinc finger motif (ZF, grey). (A) Major 
ZNF746 isoform designated Z746a (represented by UniProtKB: Q6NUN9) containing a truncated 
KRAB-A domain indicated by a gap in the depiction for highlighting. (B) ZNF746 isoform designated 
Z746b (represented by UniProtKB: A0A2R8YDQ5) with a full-length KRAB-A domain. (C) ZNF777 
protein designated Z777 (UniProtKB: Q9ULD5-2). 
The expression of GAL4 fusions in HeLa cells (Fig. 11) and HAP1 cells (Fig.12) was 




All transfected cells showed reliable expression bands, the amino parts of both ZNF746 
isoforms (Z746a/1-279 and Z746b/1-294) showed degradation bands in HeLa cells (Fig. 11B). 
 
Fig. 11: Verification of Gal4 fusion protein expression of expected size encoded by the constructed 
pM3 expression vectors by Western blotting in HeLa cells. The bands show the protein expression of 
2µg effector plasmid (pM3 vector). HeLa extracts made 24 hours post-transfection with 1 x SDS 
sample buffer were probed with rabbit polyclonal antibodies against GAL4 and monoclonal 
antibodies against endogenous GAPDH. Non-transfected HeLa cell lysates are used as negative 
controls. Note that the higher molecular weight bands for GAL4-Z746a/1-279 and GAL4-Z746b/1-294 
correspond to the computed molecular weight for GAL4-Z746a/1-279 and GAL4-Z746b/1-294 (48 and 
50 kD, respectively). Moreover, full-length ZNF746a and full-length ZNF777 show significant weaker 
bands as compared to other bands. Arrowheads point to bands of expected size; * indicates unspecific 
bands recognized by the antibodies. 
It is worth mentioning that some bands of higher molecular weight appear in some lanes 
(indicated with blue asterisks in Fig. 12). These bands could be posttranslationally modified 
products e.g. SUMOylation that was reported for ZNF746 (Nishida and Yamada, 2016) and 





Fig. 12: Verification of Gal4 fusion protein expression of expected size encoded by the constructed 
pM3 expression vectors by Western blotting in HAP1 wildtype cells. The cells were transfected, lysed, 
and analyzed as described in Fig.11. The bands indicated with blue asterisks might be modified 
proteins by SUMOylation.  
Stable cell lines expressing GST-Z746a/1-279 and GST were generated (see methods). The 
expression levels and spatial distribution of induced proteins were evaluated by Western 
blotting and immunofluorescence (Fig. 13). The stable cell lines could efficiently express 
GST and GSTZ746a/1-279 as compared with transiently transfected cells. In addition, as 
observed in HeLa cells for GAL4-Z746a/1-279, multiple degradation bands were observed. 
 
Fig. 13: Analysis of stable HEK293 cell lines expressing GST alone or GST-Z746a/1-279.              
(A) Western blot analysis of total protein extracts from six clones that survived under the selection of 
hygromycin B (2 express GST and 4 express GST-Z746a/1-279) (see methods) alongside extracts from 
parent cell line Flp-in T-REx-239 cells (negative control) and transiently transfected parent cells 
expressing GST or GST-Z746a/1-279 (positive controls). Extracts made with 1x SDS sample buffer 
after a 24-hour induction of expression with 2µg/ml Tetracycline and immunostaining with anti-GST 
(upper blot) and anti-GAPDH (lower blot) antibodies. Protein bands of the expected size are indicated 
by arrows. * indicates unspecific bands recognized by the antibodies. (B) indirect 




expressing GST-Z746a/1-279 (bottom). The cells were allowed to grow onto glass coverslips that pre-
coated with poly-L-lysine. 24h post-induction, the cells were fixed and stained with monoclonal 
antibodies against GST (in green), polyclonal antibodies against GST (in red), and DAPI (4’-6-
diamidino-2-phenylindole) to stain the cell nuclei (in blue). The fluorescence images show that GST 
and GST-Z746a/1-279 localize to cytoplasm and nuclei almost homogeneously. 
For the expression of recombinant proteins in E. coli, the bacteria were transformed with 
tagged DUF3669 of ZNF746 and ZNF777. The Western blotting analysis was used to 
evaluate expression levels. Different volumes of crude extracts were loaded into the gel to 
optimize the volumes needed for pulldown assays. All tagged proteins showed reliable bands 
but the expression efficiencies obviously varied.   
 
Fig. 14: Expression of recombinant DUF3669 in E. coli. SoluBL21 (DE3) competent E. coli were 
transformed with 10ng of the indicated prokaryotic expression vector. The protein expression was 
induced by adding 0.1mM IPTG to the bacterial suspensions at OD600= 0.4-0.6. Non-induced 
bacteria were lysed with 1xSDS sample buffer (ni lanes, 25µl), bacteria suspension after 4h induction 
with IPTG were lysed with 1xSDS sample buffer (i lanes, 25µl). The induced bacteria were briefly 
washed with 1x ice-cooled PBS, resuspended with lysis buffer and lysed by sonication. Different 




5.3- Contribution of the protein domain setup of ZNF746 to 
its transcriptional repression activities  
To assess the impact of the N-terminal domain setup on transcriptional repression specific 
expression constructs of ZNF746 (two isoforms with respect to truncated or complete KRAB-
A subdomain) were tested using a classical heterologous reporter assay. ZNF10 (also known 
as KOX1) was used as a positive control because it is well known as a robust transcriptional 
repressor through its KRAB-A box (Margolin et al., 1994). For simplicity, the term “amino 
half” of ZNF746 will be used to denote ZNF746 without zinc finger motifs corresponding to 
the configuration; DUF3669-KRAB-Exons 5 and 6. Tables contain repression factors of all 
tested constructs used to generate the bar charts in this study are found in supplements S3-S20.  
The truncated KRAB domain of ZNF746a (aa 94-173) did not exhibit any repression activity, 
while the amino half (aa 1-279) displayed the highest repression activity among all tested 
ZNF746a-derived fragments indicating the necessity of all amino-terminal domains for 
reaching the efficient repression activity (Fig. 15B). In addition, the DUF3669-containing 
segment of ZNF746a without further sequences (aa 1-108) caused downregulation of 2.7-fold. 
The protein region of ZNF746a corresponding to DUF3669 followed by the KRAB domain 
caused slight transcriptional repression (1.4-fold) and the ZNF746a portion that hooked up 
KRAB to the exons 5/6 caused downregulation of 2.7-fold. It is noteworthy that full-length 
ZNF746a exhibited transcriptional repression of 3.1-fold in HeLa and 3.9-fold in HAP1, 
which is less than the fold changes caused by its amino half (aa1-279). One reason might be 
expression disparities of effector plasmids in regard to protein levels since the expression 
analysis of 2µg pM3-Z746a by Western blotting showed a weaker band than that of pM3-
Z746a/1-279 (Fig. 11 and Fig. 12). Moreover, the protein region of zinc finger motifs caused 
a weak downregulation of 2-fold.  
On the other side, the KRAB domain isoform with non-truncated KRAB-A of ZNF746b 
(aa109-188) caused downregulation of 3.1-fold (Fig. 15C). The amino half of ZNF746b (aa 1-
294) exhibited the most potent transcriptional repressive activity amongst all tested effector 
plasmids of this isoform (12.5-fold). It reached about 70% of repression potential achieved by 
the robust repressor KRAB domain of ZNF10 alone. Significant enhancement in repression 
activities was also shown by the protein regions of ZNF746b corresponding to DUF3669-






Fig. 15: Contribution of different protein domains to the transcriptional repressor activities of 
ZNF746 and ZNF777. Heterologous reporter assay data using fusions of the indicated protein 
segments with the Gal4 DBD in human HeLa cells. The fusion of the ZNF10 KRAB domain (KRAB-AB) 
was used as a positive control and reference for potent repressor activity. This reference is included in 
each subfigure plot. (A) Illustration of assay; only the firefly luciferase reporter plasmid harbors 
upstream Gal4 DNA-DBS and its expression was normalized to the expression of Renilla luciferase 
plasmid that does not have GAL4-DBS. (B) Repressor potency of isoform ZNF746a and its selected 
segments. (C) Repression factors of segments derived from ZNF746b. (D) Repressor activity of 
ZNF777 and its selected segments. Bar plots represent normalized mean repression factor values ± 
STDEV of six biological replicates from three independent experiments relative to experiment-specific 
values for the Gal4-DBD alone. Asterisks indicate results of a two-tailed unpaired t-test (one asterisk 
* p<0.05, two asterisks ** p<0.01 and three asterisks *** p<0.001). 
These findings showed that the overall repression activity of ZNF746 is not attributed to the 
KRAB domain alone. Even though the KRAB domain of ZNF746a is inactive as a 
transcriptional repressor; the presence of DUF3669 and the protein region encoded by exons 5 
and 6 lead to the establishment of an N-terminal domain array with moderate transcriptional 
repression capacity. Full-length KRAB domain of ZNF746 is a functional transcriptional 
repressor, and the extension by DUF3669 and/or exons 5/6 regions exhibited significant 
increments of transcriptional repressive potential compared to their ZNF746a counterparts. 
In brief, reporter assay data showed that the whole N-terminal configuration of DUF3669, 
KRAB, and exons 5/6 segment interdependently contribute to the repression potential of 
ZNF746. It is quite clear that the repressive isoform of the KRAB domain is more influenced 




5.4- Impact of the ZNF777 domain organization on 
transcriptional repression 
ZNF777 contains the amino-terminal DUF3669 in addition to a KRAB domain with a 
complete KRAB-A subdomain and nine zinc finger motifs (Fig. 10C). The KRAB-AB 
domain of ZNF777 (aa283-362) caused a neglectable downregulation even though its KRAB-
A subdomain is non-truncated and matches the KRAB-A of ZNF746b (Fig. 15D, Fig. 17C 
blue bars). Furthermore, the configuration DUF3669-KRAB (aa 1-362) in ZNF777 caused a 
weak downregulation of 2-fold only in HAP1 cells (Fig. 17C). The DUF3669-containing 
segment (aa1-282) caused a weak repression activity of 2.5-fold in HeLa and 4.1-fold in 
HAP1. The part of the amino terminus that matches the consensus of DUF3669 (PF12417) (aa 
189-254) caused a weak downregulation of 2-fold in HeLa cells and 1.4-fold in HAP1 cells. 
Full-length ZNF777 (aa1-831) showed with 4.2- (HeLa) and 6.3-fold (HAP1) a clearcut and 
compared to ZNF10AB moderate transcriptional repression potential although its KRAB-AB 
alone was a very poor transcriptional repressor. The last result indicates again (as shown for 
ZNF746) that ZNF777 requires the DUF3669 domain and maybe the exon 4 encoded residues 
for its repressive activity. 
DUF3669 of ZNF746 and ZNF777 are transcriptional repressors. By comparison, the protein 
region of ZNF777 that matches the consensus of DUF3669 (PF12417) (aa189-254) failed to 
preserve the repression potency of the longer version of DUF3669-containing fragment (aa1-
282). This indicates that this sequence is insufficient to reach a full-function as a 
transcriptional repressor, Fig.24 shows alignment of all human DUF3669 domains. 
The poor repression activity of the KRAB domain of ZNF777 although its KRAB-A 
subdomain is similar to the KRAB-A subdomain of ZNF746b (Fig 16), could be explained by 
the differences in individual residues, maybe in the KRAB-B domain that can stimulate 
KRAB-A-repressive activity (Vissing et al., 1995).   
Z746a_KRAB-A      WILRLPPGSKGESPKEWGKLEDWQKELYKHVMRGNYETLVSLD 
Z746b_KRAB-A      VPVTFDDVAVYFSEQEWGKLEDWQKELYKHVMRGNYETLVSLD 
Z777_KRAB-A       VPVTFDDVAVHFSEQEWGNLSEWQKELYKNVMRGNYESLVSMD 
                    : :   :   * :***:*.:*******:*******:***:*  
  
Z10_KRAB-A        TLVTFKDVFVDFTREEWKLLDTAQQIVYRNVMLENYKNLVSLG 








Z746a_KRAB-B      YAISKPEVLSQIEQGKEPCNWRRPGPKIPDVPVDPSP 
Z746b_KRAB-B      YAISKPEVLSQIEQGKEPCNWRRPGPKIPDVPVDPSP 
Z777_KRAB-B       YAISKPDLMSQMERGERPTMQEQEDSEEGETPTDPSA 
                  ******:::**:*:*:.*   .: ..:  :.*.***. 
 
Z10_KRAB-B        YQLTKPDVILRLEKGEEPWLVEREIHQETHP------ 
                  * ::**::: ::*:*:.*   .:   :  .  
Fig.16: Multiple alignment of amino acid sequences of KRAB-A subdomains and KRAB-B 
subdomains of ZNF746b, ZNF777, and ZNF10. Multiple alignment was conducted using Clustal 
tool, ‘’W’’ version. (https://www.genome.jp/tools-bin/clustalw). The color code according to chemical 
properties; polar in green (G, S, T, Y, C), neutral in purple (Q, N), basic in blue (K, R, H), acidic in 
red (D, E), and hydrophobic in black (A, V, L, I, P, W, F, M). The highlighted polypeptide in yellow 
displays the amino acids from the neighbouring   protein region to fill the truncated region of the 
KRAB-A in the isoform ZNF746a. 
 
5.5- Evaluation of the dependency of ZNF746 and ZNF777 
repressor potential on TRIM28 and SETDB1 
The prevailing view is that interaction with TRIM28 is indispensable for a KRAB domain to 
function as a transcriptional repressor. TRIM28, in turn, recruits SETDB1 (histone 
methyltransferase) and NuRD complex (contains histone deacetylase activity) to the genomic 
locus target and subsequently confers epigenetic modulation and transcriptional repression 
(Fig. 3).  
This stage of work aimed to investigate to what extent the transcriptional repression activities 
of constructed protein regions of ZNF777 and ZNF746 are dependent on the presence of 
TRIM28 and SETDB1. Dual reporter assays were performed in HAP1 wildtype, HAP1-
TRIM28 knockout, and HAP1-SETDB1 knockout cells (Fig. 17). The canonical KRAB 
domain of ZNF10 is used as a positive control in all cell lines because ZNF10 was originally 
utilized to isolate TRIM28, and the interaction with TRIM28 has long been well-characterized 
(Friedman et al., 1996). Lists show the repession factors of all tested constructs in HAP1 cells 
are found in supplements S7-S15. As expected, the robust transcriptional repression caused by 
the KRAB domain of ZNF10 in HAP1 wildtype was completely abolished in HAP1-
TRIM28ko cells and drastically declined in HAP1-SETDB1ko.  
In terms of ZNF746a-derived protein fragments, as observed in HeLa cells, the highest 
repression activity was caused by the amino half that corresponds to DUF3669-KRAB-
exons5/6 (7.2-fold, Fig. 17A). This repression activity decreased by almost half in TRIM28 
knockout cells (3.8-fold) suggesting that their transcriptional repression function dependent 




observed by a significant decrease in repression activities in SETDB1 knockout cells (2.3-
fold). Unlike ZNF746a-amino half, the transcriptional repressive activity of full-length 
ZNF746a appears to be independent of TRIM28 and SETDB1. The repression activities 
caused by the ZFs-containing fragment of ZNF746 (aa 280-644) appear to be independent of 
TRIM28 but dependent on SETDB1. Moreover, DUF3669 of ZNF746 and ZNF777 displayed 
dependency on TRIM28 and SETDB1.  
The full-length KRAB domain of ZNF746 showed complete dependency on TRIM28 and 
SETDB1 (Fig. 17B). Moreover, the repression activities caused by all amino-terminal 
segments of ZNF746b declined significantly in TRIM28ko and SETDB1ko cells suggesting 
that their repressive activities are dependent on the presence of TRIM28 and SETDB1. Of 
note, robust repressive activity caused by amino half of ZNF746b did not reach the basal 
expression levels in knockout cells. Interestingly, despite demonstrating distinct 
transcriptional repressive capacities in wild type cells, the amino halves of both isoforms 
(Z746a/1-279 and ZNF746b/1-294) showed very comparable values in knockout cells (Fig. 
17A and B). In addition, both amino halves of ZNF746 showed higher repression activity in 
TRIM28ko than in SETDB1ko cells. Altogether, the results in HAP1 cells suggest a TRIM28-






Fig. 16: Dependency of the transcriptional repressive activities of ZNF746- and ZNF777-derived 
protein segments on TRIM28 and SETDB1. Results of dual-luciferase reporter assays using Gal4-
DBD fusions of the indicated protein segments. The respective ZNF10 KRAB domain (KRAB-AB) 
construct served as a positive control for a KRAB repressor dependent on TRIM28 and SETDB1. (A) 
ZNF746a-derived protein fragments (B) ZNF746b-derived protein fragments (C) ZNF777-derived 
protein fragments. For each GAL4 fusion protein, the transcriptional repressive activities were 
evaluated in human HAP1 wild type (blue bars), human TRIM28 knockout HAP1 cells (orange bars), 
and human SETDB1 knockout HAP1 cells (grey bars). Bars depict normalized mean repression factor 
values ± STDEV of six biological replicates from at least three independent experiments relative to 
experiment-specific and cell-type-specific values for the Gal4-DBD alone. Asterisks indicate results of 
a two-tailed unpaired t-test (one asterisk * p<0.05, two asterisks ** p<0.01 and three asterisks *** 
p<0.001; n.s. = no statistical significance, i.e. p>0.05) when comparing knockout with wildtype data 




Full-length ZNF777 caused downregulation of the reporter gene by 6.3-fold in HAP1 
wildtype cells. ZNF777 caused also repression activities in TRIM28ko cells (3.8-fold 
repression) and SETDB1ko cells (3.2-fold repression) suggesting that ZNF777-mediated 
repression activity is partially dependent on TRIM28  
In brief, the presence of both DUF3669 and exons 5/6 in the amino halves of ZNF746 
isoforms caused a significant enhancement in the repression activities not only in TRIM28-
dependent manner but also through TRIM28-independent mechanism. Obviously, full-length 
ZNF746a and ZNF777 behave differently from their respective protein regions. Full-length 
ZNF746a appears to be independent of TRIM28 whereas full-length ZNF777 is partially 
dependent on TRIM28 and SETDB1. These data are not easy to interpret since full-length 
ZNF746a and ZNF777 contain functional zinc finger domains that bind to chromosomal 
regions whereas the GAL4-DNA binding domain binds to the GAL4 binding sites present in 
the transiently transfected reporter plasmid. Furthermore, DUF3669 containing protein 
variants could even theoretically highjack functional endogenous TRIM28/SETDB1 
complexes by forming DUF3669 containing homodimer or heterodimer complexes (see 
section 5-10). 
5.6- Investigation of the interaction between ZNF746 or-/ 
ZNF777 protein segments and endogenous TRIM28. 
Reporter assay data showed that the repression activities of several ZNF746- and ZNF777-
derived protein regions significantly declined or even disappeared in the absence of TRIM28. 
Therefore, the next logical step was to investigate whether these fragments were able to form 
stable complexes with TRIM28.  
First, a colocalization assay for all tested KRAB domains was performed (KRAB domains of 
ZNF10, ZNF746a, ZNF746b, and ZNF777). It relies on the appearance of nuclear foci for 
Gal4-KRAB fusions that can easily be checked for the enrichment of endogenous TRIM28 by 
fluorescence microscopy (Born et al., 2014). Bright foci in the same image pane of GAL4-
KRAB of ZNF10 and ZNF746b (in green) and cellular TRIM28 (in red) were observed, but 
not for the KRAB domains of ZNF746a and ZNF777 (Fig. 18). This suggests that the KRAB 
domains of ZNF746b and ZNF10 can recruit TRIM28.  
To investigate whether TRIM28 associates in the same complex with any of ZNF746- or 
ZNF777-derived protein regions, co-immunoprecipitation assay using protein G magnetic 




of GST-ZNF777 and GST-ZNF746a fusions co-precipitated with cellular TRIM28 (Fig. 19A 
and Fig.19C). 
The ZNF746b-derived GST fusions corresponding to the KRAB domain (aa 109-188), 
DUF3669-KRAB (aa 1-188) and KRAB-exons 5/6 (aa 109-294) co-associated with 
endogenous TRIM28 (Fig. 19B). However, the extent of enrichment was clearly much lower 
than for the ZNF10 KRAB domain arguing that the stability of the complex and/or affinity of 
the binding partners were inferior for ZNF746b. Conversely, the amino half of ZNF746b (aa 
1-294) could not form a stable complex with TRIM28 although its shorter versions showed 
significant association with TRIM28. This result was reproducible and confirmed when anti-
GST antibodies were used as a bait. 
Despite multiple tries with different transfection methods, it was not possible to get 
sufficiently efficient expression of full-length GST-ZNF746a and GST-ZNF777 in HeLa cells. 
Therefore, it was not possible to assess their interaction with TRIM28 in this study.  
It stands to reason that the truncated KRAB-A with ZNF746a fragments failed to form a 
stable complex with TRIM28 because it lacks the well-conserved DV and LE motifs that are 
critical for interaction with TRIM28 whereas the KRAB domain of ZNF746b with complete 
KRAB-A showed a weak interaction with TRIM28 likely because of the presence of DV 
motifs (Margolin et al., 1994). 
 
Fig. 17: Co-localization analysis of ectopically expressed GAL4-KRAB versions and cellular 




were fixed in PBS (4%/w/v) paraformaldehyde, and permeabilized in PBS, 0.5% (w/v) Triton X-100. 
Subsequently, the cells were stained for GAL4-KRAB fusion proteins (in green) and cellular TRIM28 
(in red). Both GAL4-KRAB and TRIM28 predominantly localize to the nuclei. 
 
Fig. 18: Analysis of the interaction between ZNF746 and ZNF777 protein fragments and 
endogenous TRIM28. Extracts from HeLa cells after transient expression of GST/GST-ZNF fusion 
constructs were subjected to immunoprecipitation using TRIM28 as bait. Input protein extracts (“X”) 
and eluted immunoprecipitates (“IP”) were analyzed by Western blotting. The blots were probed with 
monoclonal antibodies against TRIM28 and rabbit polyclonal antibodies against GST, followed by 
respective secondary antibodies with different fluorescent tags. Images represent black/white 
representations of cropped regions (see Methods) informative to evaluate TRIM28 precipitation 
(upper part) and GST/GST-fusion protein co-immunoprecipitation (lower parts) from the same lanes., 
White block arrows indicate GST/GST-fusion protein signals whereas the black block arrows point to 
TRIM28 bands in the input cell lysate lanes. GST alone was used as a negative control whereas the 
KRAB domain of ZNF10 served as a positive control. Further controls were obtained by mock 
immunoprecipitation from non-transfected HeLa lysates (label “HeLa”) and protein-G beads eluted 
with SDS sample buffer. (A) Results for Z746a-derived GST fusions, (B) data of Z746b-derived GST 
fusions, (C) analysis of Z777-derived GST fusions. Asterisks indicate unspecific bands. 
5.7- Lack of a conserved glutamic acid residue in ZNF746 
KRAB-A explains the weak repressor activity and 
insufficient interaction with TRIM28. 
The canonical KRAB-A subdomains display conserved amino acid motifs that have been 
found to be essential for their function to confer transcriptional repression by TRIM28 
recruitment. Accumulated evidence indicated that DV and MLE conserved sequences in the 
human KRAB-A consensus are essential for TRIM28 binding and thereby transcriptional 




protein (Witzgall et al., 1994); in KRAB-O (Peng et al., 2009), and mouse ZFP568 (Murphy 
et al., 2016). 
Sequence analysis revealed that MLE motif is replaced by MRG in the KRAB-A of the 
isoform ZNF746b. The KRAB domain of ZNF746b (Z746b/109-188) displayed a weak 
downregulation of about 3-fold and weak interaction with TRIM28. Thus, we asked whether 
the absence of leucine (L), glutamic acid (E), or both are responsible for its weak 
transcriptional repressive capacity as well as its weak interaction with TRIM28. Substitution 
mutations were generated; Z746b/109-188_R141L, Z746b/109-188_G142E, and Z746b/109-
188_RG/LE. The transcriptional repressive activity and the interaction with TRIM28 were 
tested with all mutant KRAB domains (Fig. 20). 
The results showed that the mutant Z746b/109-188_R141L did not exhibit any improvement 
in either repression activity or its ability to interact with TRIM28. In contrast, the replacement 
of glycine with glutamic acid in the mutant Z746b/109-188_G142E caused a drastic increase 
in transcriptional repression activity to a factor of 41-fold repression and concomitantly 
significant recruitment of TRIM28. The double mutant Z746b/109-188_RG/LE did not 
improve transcriptional repressive activity or TRIM28 interaction further. The results 
suggested that the glutamic acid residue at its specific position within the MLE conserved 
motif was the most essential for KRAB-mediated repression activity by improving the 
interaction with TRIM28. One explanation might be its negative charge that can pair with 





Fig.20: Mutation to a conserved acidic residue in KRAB-A strongly improved the repression activity 
and TRIM28 interaction of the ZNF746b KRAB-AB domain. (A) Multiple alignment of the KRAB-A 
amino acid residues of ZNF10, ZNF746b and three ZNF746 mutants, R141L, G142E, and RG/LE. The 
amino acids highlighted in yellow indicate agreement with the amino acids that have been previously 
confirmed to be necessary for potent transcriptional repression activity and stable interaction with 
TRIM28. Mutated residues in ZNF746b are highlighted by black boxes. (B) Comparison of 
transcriptional repression activities of wild type KRAB-AB of ZNF746b, and the three configurations 
with the indicated mutated residues in KRAB-A in HAP1 wild type (blue bars), TRIM28ko (orange 
bars), and SETDB1ko cell lines (grey bars). ZNF10-AB is used as a positive control. Results of dual-
luciferase assays presenting mean repression factor values ± STDEV of six biological samples from 
three independent experiments. Asterisks indicate results of a two-tailed unpaired t-test (* p<0.05; ** 
p<0.01; *** p<0.001; n.s.= not significant, i.e. p>0.05) (C) Analysis of complex formation of GST-
KRAB-AB fusion proteins with TRIM28 in HeLa cells using co-immunoprecipitation and endogenous 
TRIM28 as bait as described in Fig. 19. Grey block arrows point to endogenous TRIM28 in the lysate 





5.8- Lack of transferability of the DUF3669 effect on 
repression to a canonical KRAB domain 
The protein region of ZNF746b corresponding to DUF3669-KRAB (aa 1-188) showed a 
substantial enhancement in transcriptional repression as compared to its respective KRAB 
domain (Fig. 15C and Fig.17B); this level of repression improvement was not observed when 
the KRAB domain was not active as a transcriptional repressor as shown in ZNF746a (aa 1-
173) and in ZNF777 (aa 1-362). This might imply that DUF3669 might fine-tune the 
transcriptional repressive potential of KRAB domains, particularly when the KRAB domain is 
a transcriptional repressor. Furthermore, transcriptionally inactive KRAB domains might even 
be favored in concert with DUF3669 domains to introduce and gain extended regulatory 
potential. 
To examine whether DUF3669 could inherently support the transcriptional repressive 
potential of a potent canonical KRAB domain, the DUF3669 of ZNF746 (aa1-108) and 
ZNF777 (aa189-254) were chimerically linked to the amino terminus of the KRAB-AB 
domain of ZNF10. The transcriptional repression potentials of DUF3669-Z10AB were 
evaluated in HAP1 cells. As shown in Fig. 21A, the chimeric proteins did not show any 
significant changes in transcriptional repression potential. This finding suggests that 
DUF3669 functions as an enhancer of KRAB domain functionality in its authentic 
configuration. Of note, Z746a/1-108-Z10AB showed some residual repression activity in 
HAP1-TRIM28ko which might suggest that DUF3669 of ZNF746 can attenuate the 
dependency of transcriptional repressive activities on TRIM28. 
 
Fig.21: (A) Impact of DUF3669 domains from ZNF746a and ZNF777 on the repressor activity of 
ZNF10-KRAB-AB. Wildtype ZNF10-AB and fusions of ZNF10-AB to DUF3669 domain segments from 
ZNF746a or ZNF777 were analyzed by dual-luciferase activities in HAP1 wildtype, SETDB1 and 
TRIM28 knockout cells as in Fig. 17. (B) Mutation of a major SUMO-acceptor lysine (K189R) in the 




cells (orange bars). Dual-luciferase reporter assay as in Fig. 15. Bars visualize mean repression 
factor values ± STDEV of six biological samples from three independent experiments. Asterisks 
indicate results of a two-tailed unpaired t-test (*** p<0.001; n.s. = not significant, i.e. p>0.05). 
5.9- SUMOylation at K189 in ZNF746a is critical for its 
transcriptional repression activities 
Nishida and Yamada (2016) reported that ZNF746 has two primary SUMOylation target sites 
(K189 and K286 in isoform a) and that the SUMOylation of ZNF746 regulates its repressive 
activity in a cell type-dependent manner (HeLa and HAP1cells were not studied) (Nishida and 
Yamada, 2016). K189 is located within the protein region of ZNF746 encoded by exon 5, 
whereas K286 is located within the amino terminus of the ZFs-containing fragment encoded 
by exon 7. Reporter assay results showed that the protein regions of KRAB-exons 5/6 in 
ZNF746a and ZNF746b caused a significant enhancement in their repressive activities. 
To evaluate if the SUMOylation at K189 affects the transcriptional repression of ZNF746a, a 
K to R amino acid replacement mutation was generated at K189 in the ZNF746a/1-279 
fragment. The transcriptional repression activities caused by this mutant protein were 
evaluated in HeLa and HAP1 cells (Fig. 21B). Compared to the wildtype ZNF746a/1-279 
portion that caused reporter repression of 4.2-fold in HeLa and 7.2-fold in HAP1, the 
ZNF746a/1-297K189R mutant failed to exert a clearcut repressive activity (residual 
repression factor of 1.3-fold in HeLa and 0.8 in HAP1 cells). This strongly suggests that 
SUMOylation at K189 is crucial for ZNF746a repression activities in the studied cell models. 
The mutant ZNF746a/1-279K189R failed to achieve repressive activity although it still 
contains an intact DUF3669 domain. The abolishment of repression that resulted from the 
disruption of SUMOylation at lysine 189 predominates over the repression enhancement that 
is probably caused by the DUF3669 domain. Further investigation is still required to examine 
if the SUMOylation plays the same role in the other isoform of ZNF746. 
5.10- Investigation of DUF3669 Homo- and Hetero-
oligomerization 
To investigate whether DUF3669 is able to oligomerize, we first interrogated data sets 
determined by BioPlex 2.0 for shared complexes between members of the DUF3669-KRAB-
ZNF proteins. Both, ZNF746 and ZNF777, were found to associate with two DUF3669-
containing KRAB-ZNF proteins (ZNF212 and ZNF 398) in large-scale affinity purification-




ZNF746 nor ZNF777 was used as bait in these studies, existence in the same complex was not 
formally proven. 
Self-association of ZNF212 has been previously reported (Gao et al., 2008). Importantly, the 
tandem-affinity purification method showed that ZNF746 interacts with ZNF212, ZNF282, 
ZNF746, and ZNF783. These ZNF proteins are DUF3669-containing proteins (Kang and Shin, 
2015) (Fig.25). As these data suggested, we decided to prove whether these associations occur 
through DUF3669.  
The stable cells expressing either GST or GST-Z746a/1-279 were tranfected with either One 
Strep tagged-Z777/1-362 (OST- Z777/1-362) or One Strep taggd-Z777/1-282 (OST-Z777/1-
282) that harbor the amino acid sequence of DUF3669. Reciprocal pulldown assays were 
conducted using either Protein G magnetic beads loaded with polyclonal antibodies against 
GST or Strep-Tactin resin. As depicted in Fig. 22B, the amino half of ZNF746a reciprocally 
co-associated with ZNF777/1-362 and with ZNF777/1-282. The enrichments using Strep-
Tactin resin were more efficient than the immunoprecipitations using protein G magnetic 
beads. Since DUF3669 is present in all tested fusions and the KRAB is not known to elicit 
oligomerization, these co-associations most likely occurred through DUF3669. 
To consolidate this finding, HeLa cells were transiently transfected with expression plasmids 
of DUF3669 containing segments of ZNF746a (aa1-108) and ZNF777 (aa189-254 and aa1-
282) (Fig. 22C). Self-association of ZNF746a/1-108 encompassing DUF3669 and co-
association between ZNF746a/1-108 and both DUF3669-containing segments of ZNF777 
(aa1-282 and aa189-254) were observed. In contrast, DUF3669 of ZNF777 failed to show 
self-association. To ascertain that the inability of DUF3669 of ZNF777 to form homo-
oligomers was not due to the tag, an alternative experiment was performed that replaced the 
OST- with a GFP-tag (Fig. 22D). In conclusion, the results demonstrated that DUF3669 of 
ZNF746 is able to form homo- and heterooligomers, whereas DUF3669 of ZNF777 
contributed to hetero-oligomers but failed to form homo-oligomers  
In order to show physical direct homo- and hetero-association without the presence of 
additional eukaryotic cell proteins or the need for post-translational modifications, pull-down 
assays were done with recombinant DUF3669 protein extracts from E. coli. In agreement with 
the previous results from eukaryotic cells, DUF3669-containing segment of ZNF746 (aa1-108) 
was able to homo- and hetero-associate with other DUF3669-containing segments of ZNF777 






Fig. 22: In vivo evaluation of homo- and hetero-oligomerization of DUF3669 of Z746 and Z777.   
(A) First-neighbor networks from the BioPlex2.0 project (Huttlin et al., 2017) for ZNF746 (left) and 
ZNF777 (right) indicate shared complexes of different DUF3669-containing ZNF proteins in HEK293 
cells. A purple rhombus denotes the center of the network (ZNF746 and ZNF777, respectively), and 
the circle represents a bait node. DUF3369 -containing ZNF proteins are represented in red circles. 
Note that both, ZNF746 and ZNF777, were found to form complexes with DUF3669-containing ZNF 
proteins ZNF212 and ZNF 398. (B) Analysis of oligomerization between N-terminal fragments of 
ZNF746 and ZNF777. HEK293 cells that stably express either GST or GST-Z746a/1-279 were 
transiently transfected with either Z777/1-362 or Z777/1-282 tagged with a One-Strep-Tag (OST). 




labeled “IP”) or by pull-down using Strep-Tactin via the OST (lanes “P”) were analyzed by Western 
blotting alongside an aliquot of the input extract (lanes “X”) with GST and OST antibodies as 
indicated. White arrows point to GST bands whereas grey arrows point to OST bands in the input 
lanes (X lanes). (C) Narrowing down of the protein oligomerization domains and analysis of homo-
oligomerization. HeLa cells were transfected with the indicated GST/GST-fusion and OST-fusion 
constructs and subjected to Strep-Tactin pulldown via the OST-tagged proteins. Western blots 
interrogated the input extracts and the enriched fractions (lanes labeled “X” and “P”, respectively) 
using anti-GST and anti-OST antibodies in different color channels. (D) An alternative analysis of 
ZNF777 homo-oligomerization using HeLa cells transfected with GST/GST-fusion and GFP/GFP-
fusion constructs. Enriched proteins from GST pulldown via glutathione beads (lanes “P”) were 
probed with anti-GST and anti-GFP antibodies. White arrows point to GST bands whereas black 
arrows point to GFP bands in the input extracts (lanes “X”). 
 
 
Fig. 19: Evaluation of homo- and hetero-dimerization of DUF3669-containing fragments of 
ZNF746 and ZNF777 in E. coli. Bacterial extracts with the indicated recombinant proteins were 
mixed and Ni-NTA beads were used to pull-down His-tagged proteins. Western blots probed with anti-
His tag antibodies and GST or MBP tag antibodies were used to visualize the proteins in the input 
extracts (lanes “X”) and to identify the enriched recombinant proteins. GST alone and MBP alone 
were used as negative controls. Grey arrows denote His-tagged proteins, white arrows point to GST 
and GST fusion bands and black arrows point to MBP and MBP fusion proteins. 
These findings establish DUF3669 as a novel protein oligomerization domain and suggest that 






KRAB-ZNFs are known for their powerful transcriptional repressor potentials (Margolin et al., 
1994; Pengue et al., 1994; Witzgall et al., 1994; Pengue and Lania, 1996); however, their 
endogenous targets and biological functions appear to be essential in tetrapod physiology. 
Although the canonical KRAB/TRIM28 model has been well characterized, the current 
knowledge about the transcriptional repression activities of individual KRAB-ZNFs is limited 
to a few well-characterized KRAB-ZNF proteins. Conversely, several studies reported the 
involvement of several KRAB-ZNF proteins in transcriptional activation (W. Chen et al., 
2019; Hallen et al., 2011; Losson and Nielsen, 2010; Mysliwiec et al., 2007). Moreover, some 
members also failed to stably interact with TRIM28 despite trans-repressor activity (Itokawa 
et al., 2009; Murphy et al., 2016). 
This study investigated two members of DUF3669-containing KRAB-ZNF subfamily; 
ZNF746 and ZNF777 in terms of the repression activities of their unusual amino termini 
including their protein oligomerization behavior. The reporter assay results showed that 
DUF3996 present in ZNF746 and ZNF777 behave as intrinsic transcriptional repressors. In 
accordance with the results in this study, the protein region that is now known as 
corresponding to DUF3669 in the paralogous ZNF282/HUB1 was reported to have 
transcriptional repression activity (Okumura et al., 1997). Our analysis suggests that the 
repression activity of DUF3669 is a conserved feature of this domain. 
Here, this work established DUF3669 amino acid sequences as protein interaction interfaces 
for oligomerization. While the DUF3669 of ZNF746 forms homo- and hetero-association, 
DUF3669 of ZNF777 forms hetero-association but not homo-association. Just recently, 
during the writing of this thesis, Helleboid and coauthors published their work in which they 
reported that the DUF3669 of ZNF282 and ZNF398 co-associate in the same protein complex, 
however, without showing direct physical interaction (Helleboid et al., 2019). DUF3669 
domains of ZNF746 and ZNF777 have a very similar amino acid sequence but they behave 
differently in terms of their ability to form homo-oligomers. This suggests that only a few 
amino acids in DUF3669 of ZNF777 might be responsible for the missing of self-association 
property. Two versions of DUF3369-containing fragments of ZNF777 were tested; one 






 DUF3669_Z746 ------------------------------------------------------------ 
 DUF3669_Z212 ------------------------------------------------------------ 
 DUF3669_Z783 ------------------------------------------------------------ 
 DUF3669_Z777 MENQRSSPLSFPSVPQEETLRQAPAGLPRETLFQSRVLPPKEIPSLSPTIPRQGSLPQTS 
 DUF3669_Z398 ------------------------------------------------------------ 
 DUF3669_Z767 ------------------------------------------------------------ 
 DUF3669_Z282 ------------------------------------------------------------ 
                                                                           
 
 DUF3669_Z746 ------------------------------------------------------------ 
 DUF3669_Z212 ------------------------------------------------------------ 
 DUF3669_Z783 ------------------------------------------------------------ 
 DUF3669_Z777 SAPKQETSGRMPHVLQKGPSLLCSAASEQETSLQGPLASQEGTQYPPPAAAEQEVSLLSH 
 DUF3669_Z398 ------------------------------------------------------------ 
 DUF3669_Z767 ------------------------------------------------------------ 
 DUF3669_Z282 ------------------MQFVSTRPQPQQLGIQGLGLDSGSWSWAQALPPEEVCHQEPA 
                                                                           
 
 DUF3669_Z746 ------------------------------------------------------MAEAVA 
 DUF3669_Z212 ---------MAESAPARHRRKRRSTPLTSSTLPSQAT---------------EKSSYFQT 
 DUF3669_Z783 ---------MAEAAPARDPETDKHTEDQSPSTPLPQP-------------AAEKNSYLYS 
 DUF3669_Z777 SPHHQEAPVHSPEAPEKDPLTLSPTVPETDMDPLLQSPVSQKDTPFQISSAVQKEQPLPT 
 DUF3669_Z398 ---------MAEAAPAPTSEWDSECLTSLQPLPLPTPP-------------AANEAHLQT 
 DUF3669_Z767 ------------------------------------------------------MEEAAA 
 DUF3669_Z282 LRGEMAEGMPPMQAQEWDMDARRPMPFQFPPFPDRAPVFPDR---------MMREPQLPT 
                                                                         : 
 
 DUF3669_Z746 APISPWTMAATIQAMERKIESQAARLLSLEGRTGMAEKKLADCEKTAVEFGNQLEGKWAV 
 DUF3669_Z212 TEISLWTVVAAIQAVEKKMESQAARLQSLEGRTGTAEKKLADCEKMAVEFGNQLEGKWAV 
 DUF3669_Z783 TEITLWTVVAAIQALEKKVDSCLTRLLTLEGRTGTAEKKLADCEKTAVEFGNQLEGKWAV 
 DUF3669_Z777 AEITRLAVWAAVQAVERKLEAQAMRLLTLEGRTGTNEKKIADCEKTAVEFANHLESKWVV 
 DUF3669_Z398 AAISLWTVVAAVQAIERKVEIHSRRLLHLEGRTGTAEKKLASCEKTVTELGNQLEGKWAV 
 DUF3669_Z767 APISPWTMAATIQAMERKIESQAAHLLSLEGQTGMAEKKLADCEKTAVEFGNQLEGKWAV 
 DUF3669_Z282 AEISLWTVVAAIQAVERKVDAQASQLLNLEGRTGTAEKKLADCEKTAVEFGNHMESKWAV 
              : *:  :: *::**:*:*::    :*  ***:**  ***:*.*** ..*:.*::*.**.* 
 
 DUF3669_Z746 LGTLLQEYGLLQRRLENVENLLRNRNFWILRLPPGSKGESPK 
 DUF3669_Z212 LGTLLQEYGLLQRRLENVENLLRNRNFWILRLPPGSKGEAPK 
 DUF3669_Z783 LGTLLQEYGLLQRRLENVENLLRNRNFWILRLPPGSKGEAPK 
 DUF3669_Z777 LGTLLQEYGLLQRRLENMENLLKNRNFWILRLPPGSNGEVPK 
 DUF3669_Z398 LGTLLQEYGLLQRRLENLENLLRNRNFWILRLPPGIKGDIPK 
 DUF3669_Z767 LGTLLQEYGLLQRRLENVENLLHNRNFWILRLPPGSKGESPK 
 DUF3669_Z282 LGTLLQEYGLLQRRLENLENLLRNRNFWVLRLPPGSKGEAPK 
              *****************:****:*****:****** :*: ** 
 
 
Fig. 24: Multiple alignment of human DUF3669-containing fragments encoded by single 
exons. Alignment was performed and the color code as in the Fig.16. Amino acids highlighted 
in yellow represent the amino acids that match Pfam12417. Amino acids highlighted in 
orange represent the highly conserved fragment that might be an extension for DUF3669.  
 
Reporter assay results revealed significant differences in reporter gene repression, this 
suggests that PF12417 lacks some functional residues. Sequence analysis of DUF3669 
containing orthologous proteins revealed an extremely conserved 95aa consensus of 




repression activities between two DUF3669-containing segments of ZNF777 would suggest 
that this missing conserved sequence (aa255-282) contributes to the DUF3669 repression 
function.  
The oligomerization feature of DUF3669 can explain the increased repression activity of the 
amino-terminal segments of two ZNF746 isoforms and ZNF777 as compared with their 
respective KRAB domain. The repression increment was observed especially when the 
DUF3669 was followed by the non-truncated repressor KRAB domain of ZNF746b. It is 
noteworthy, that a heterologous transfer of DUF3669 failed to further augment transcriptional 
silencing mediated by potent canonical KRAB-AB domains like the one from ZNF10. The 
potent canonical KRAB-AB domain might be too dominant to observe any effects. Based on 
this, the DUF3669 can form higher-order molecular assemblies. Such complexes might be 
instrumental for function and open possibilities for context-dependent regulation if different 
DUF3669 members interact at distinct scenarios. Oligomerization thus may offer increased 
stability or provide combinatorial binding site signatures with respect to DNA binding. In 
addition, the high evolutionary conservation of DUF3669 sequences within an ortholog group 
and even between paralogs underscores the importance of DUF3669 for the ZNF746 and 
ZNF777 biological functions implying the presence of comparable synergistic functionalities. 
In addition to the contribution of DUF3669 in the transcriptional repression activity, a recent 
study highlighted that DUF3669 of ZNF398 is critical for its function. The isoform of 
ZNF398 that lacks DUF3669 enhances the ubiquitination and proteasomal degradation of P53 
through its KRAB domain, while the other isoform that has the amino-terminal DUF3669 
does not affect P53 ubiquitination (Huang et al., 2019). 
A comparison of the SCAN domain and DUF3669 identifies several astonishing common 
characteristics. Both domains are evolutionarily conserved domains and found in the amino 
termini of several KRAB-ZNFs (Huntley et al., 2006; Imbeault et al., 2017), The SCAN 
domain is an oligomerizing domain (Schumacher et al., 2000; Williams et al., 1999; Wu et al., 
2003) The contribution of the SCAN domain to the repression activity has been investigated 
in few studies. In one example, the oligomerization state of the SCAN domain of ZNF202 
was shown to be required for the interaction with TRIM28 and the transcriptional repression 
(Porsch-Ozcurumez et al., 2001). It was also reported that some SCAN-KRAB-ZNF proteins 
were transcriptional repressors although their respective isolated KRAB domain failed to 
downregulate the reporter gene and they did not interact with TRIM28 (Itokawa et al., 2009). 




reporter gene although their KRAB domains did not repress the reporter gene and did not 
interact with TRIM28. One explanation might be that the DUF3669 domain oligomerizes with 
endogenous DUF3669 containing proteins by making use of their cognate TRIM28 protein 
mediated repression. Alternatively, the DUF3669 might confer residual repression activity 
independent of TRIM28 and SETDB1.  
Little is known about the role of posttranslational modifications of KRAB-ZNFs in their 
transcriptional repression and biological function. While ubiquitination usually targets 
proteins for degradation (Glickman and Ciechanover, 2002), SUMOylation often regulates 
protein-protein interaction and alters the protein's biological function (Matunis et al., 2006). A 
handful of studies addressing the impact of SUMOylation on KRAB-ZNFs functionalities are 
available. For example, the SUMOylation of ZFP282 stabilizes the multiprotein complex with 
coiled-coil co-activator (CoCoA) and Estrogen receptor alpha (ERα) (Yu et al., 2013), and 
SUMOylation of ZNF451 is important for its nuclear localization (Karvonen et al., 2008). 
The protein region of ZNF746 encoded by exon 5 offers a SUMO-receptor lysine (Nishida 
and Yamada, 2016) and the removal of this residue in the ZNF746a abolished the repressive 
activity of the whole N-terminal DUF3669-KRAB-exons 5/6 protein fragment. The 
SUMOylation events thus might contribute to the repression activities through stabilizing the 
interaction with TRIM28 or conferring a docking surface for other proteins, e.g. histone 
modulating cofactors. 
It was previously reported that PIASy (also known as PIAS4) interacts with and SUMOylates 
ZNF746 at K189 and K286. PIASy can independently downregulate the PGC-1α promoter 
(Nishida and Yamada, 2016). On the other hand, it was shown that PIASy interacts with 
HDAC to confer transcriptional repression in vitro (Long et al., 2003). Furthermore, by 
searching for SETDB1 interaction partners archived in BioGRID 3.5 database 
(https://thebiogrid.org/), PIASy was identified as an interacting partner of SETDB1. In a 
related context, it was shown that the SUMOylation of ZNF133 enhances its transcriptional 
repressive activity. It was reported that zinc finger motifs of ZNF133 downregulates the 
reporter gene in a dose- and SUMOylation- dependent manner and the increasing amounts of 
PIAS1 (an E3 SUMO ligase) enhanced its repressive activity. It was suggested that PIAS1 
interacts with zinc finger fingers and recruits other co-repressors such as HDAC (Lee et al., 
2007). 
Taken together, PIASy might function as an adaptor for SETDB1 and HDACs as based on 




ZNF746 showed higher repression activity in TRIM28ko cells than SETDB1ko cells. 
Therefore, both amino halves of ZNF746 function through two distinct mechanisms; 
TRIM28-dependent and SETDB1-dependent mechanisms. Nevertheless, further 
investigations are required to confirm the assumption of molecular mechanisms underlying 
the PIASy-mediated repression activity. 
Of note, the ZFs-containing fragment of ZNF746 also possessed transcriptional repressive 
activity that is dependent on SETDB1 and independent of TRIM28. This part is SUMOylated 
at K289 (Nishida and Yamada, 2016) suggesting that the ZFs-containing fragment of ZNF746 
functions as a transcriptional repressor by recruiting PIASy in SETDB1-dependent and 
TRIM28-independent mechanism. 
SUMOylation might be a common mechanistic theme for the biological functions of DUF-
KRAB-ZNF proteins. Global SUMOylation analysis showed that ZNF777 is SUMOylated 
(Schimmel et al., 2014; Xiao et al., 2015). Sequence analysis revealed three SUMO-acceptor 
lysines are located within perfectly matching consensus sequences for SUMOylation 
modification (ψKXE, where ψ represents a large hydrophobic amino acid, K is the lysine 
conjugated to SUMO, X is any amino acid, and E is a glutamic acid) (Sampson et al., 2001); 
K370 is located within exon 4 encoded fragment; K370 and K689 are located in the exon 5 
that encodes zinc finger motifs region. It is tempting to speculate that SUMOylation of 
ZNF777 can contribute to its repressive functionality. SUMOylation can explain why the 
protein region of ZNF777 corresponding to DUF3669-KRAB that does not harbor any 
SUMO-receptor lysine showed a poor repression activity, whereas full-length ZNF777 caused 
significant repression that is not completely dependent on TRIM28.  
Another comprehensive SUMOylation analysis revealed that the DUF3669-containing 
KRAB-ZNFs ZNF282, ZNF398, and ZNF783 are also SUMOylated (Hendriks and Vertegaal, 
2016) but it has not yet been identified at which lysine residue. Interestingly, the “IKTE” 
SUMOylation consensus is highly conserved in the zinc finger regions within all ZNF746, 
ZNF777, and ZNF783 orthologous proteins. The conservation of this motif implies that this 
motif might be involved in the biological function of these proteins including their 
transcriptional repression activities. 
CoIP results showed that cellular TRIM28 co-associates with the protein regions of ZNF746b 
that correspond to DUF3669-KRAB and KRAB-exons 5/6. Conversely, the amino half of 
ZNF746b (aa 1-294) could not form a stable complex with TRIM28 although its shorter 




able to recruit TRIM28 since all relevant protein regions could recruit TRIM28 and for some 
reason it was not detected in the same complex. The oligomerizing property of GST can lead 
to the formation of a higher complex that might mask the TRIM28 interacting surface, or this 
truncated tagged protein may not fold properly. 
Non-of the tested ZNF746a- and ZNF777-derived protein fragments could stably associate 
with TRIM28 although most of them were partially inhibited in their moderate repressor 
activities by TRIM28 depletion. This might imply that complex formation with TRIM28 in 
cells might be very transient and could therefore not be shown by co-immunoprecipitation. 
Alternatively, the dependency might not be due to direct protein-protein interaction but to 
mechanistic links mediated through other molecules such as PIASy. 
The weak interaction between ZNF746a and ZNF777 and other two DUF3669-containing 
KRAB-ZNFs; ZNF212, ZNF398 have been recently reported even despite the use of 
crosslinking before affinity enrichment from cellular extracts (Helleboid et al., 2019; Kang 
and Shin, 2015). Current knowledge regarding previous studies and our results on interactions 
of DUF3669 containing KRAB–ZNF proteins illustrate that ZNF746 as bait interacts with 
ZNF783, ZNF777, ZNF 282 and ZNF212, whereas ZNF777 only interacts as bait with 
ZNF746 (Fig. 25).  
 
Fig. 25: Summary of the current knowledge about shared complexes of DUF3669-containing 
KRAB-ZNF proteins based on our results and previous studies.  Arrows point from bait to prey. Line 
width reflects detection in one or two (thicker line) studies. Derived from data that were based on 
affinity-purification/mass spectrometry using tagged DUF3669-KRAB-ZNF proteins (Bioplex 2.0) 




immunoprecipitation (Helleboid et al., 2019) and including the data of this study (Al Chiblak et al., 
2019).  
For the first time, this study demonstrates that ZNF746 forms direct homodimer and 
heterodimer with ZNF777 whereas ZNF777 failed to form homodimers. The issue lies in 
which single amino acids do contribute to this divergent behavior. 
Given the substantial differences in their principle capacity to silence gene expression, it will 
be important to consider which isoform happens to be involved in a certain biological context 
when studying and interpreting the cellular functions of ZNF746. The isoform-dependent 
biological function has been recently shown for ZNF398 (Huang et al., 2019). It is 
conceivable that isoform ZNF746b with full-length KRAB-A does not only show increased 
TRIM28 interaction and a boosted repressor activity like we observed here but might display 
a different overall interactome as well. ZNF746 could, therefore, be subject to a scenario in 
which differential splicing leads to the expression of protein isoforms with differential 
transcriptional/translational regulatory potentials. 
Using mutational analysis in ZNF746-A, the results of this study pinpointed the main reason 
for this difference in repression activity due to the lack of a glutamic acid residue at a 
conserved “MLE” motif of canonical KRAB-A subdomains. The results showed that glutamic 
acid alone caused an extreme increase in repressive activity even more than the KRAB 
domain of ZNF10. 
In addition, the interaction with TRIM28 was remarkably improved. Leucine did not make 
any differences. This result highlights the importance of the negative charge of glutamic acid 
to stabilize the interaction between the KRAB domain and TRIM28. The very recent studies 
published on the structural details of the TRIM28/KRAB interaction (Stoll et al., 2019; Sun et 
al., 2019) might enable the molecular modeling of the difference between glycine vs. glutamic 
acid in the future. 
The KRAB-A of all human DUF3669-containing zinc finger proteins and their orthologs 
show a common difference in comparison to canonical KRAB A domains. Interestingly, 
ZNF282 orthologs are characterized by “VKE”, i.e. there is a glutamic acid residue. 
Nevertheless, the KRAB domain of human ZNF282/HUB1 was unable to repress a reporter 
gene (Okumura et al., 1997), indicating that other amino acids besides the glutamic acid are 
also contributing to this property. The lack of LE conserved residues in KRAB-A box in 




with TRIM28 leading to reduced repression, but opening up the possibility that additional 
DUF3669 mediated functions might be executed not directly linked to TRIM28 binding. 
Altogether, the canonical KRAB/TRIM28 pathway cannot alone explain the repressive 
activities of DUF3669-containing KRAB-ZNF proteins. Other mechanisms that rely on other 
structural components are intrinsic and important for this protein subfamily.   
The gene regulation ability of the KRAB-ZNFs has been researched mainly using artificial 
systems because of the limited number of endogenous targets of KRAB-ZNFs identified up to 
now. In this study here, classical heterologous luciferase reporter assays in which the protein 
of interest is artificially targeted to DNA via the fused Gal4 DNA-binding domain was used.  
The luciferase reporter assay is a golden standard that is widely used in gene regulation 
studies to gain insight into nuclear cell biology. In this study, we relied on the dual-luciferase 
assay to evaluate the transcriptional repressive capacities of several protein regions of 
ZNF746 and ZNF777. The major concern is that this exogenous reporter plasmid may not 
give insight into the native epigenetic gene regulation machinery. The presence of proper 
chromatin configuration on such plasmid DNA is still controversial. It is not clear whether 
plasmid DNA owns a similar chromatin dynamics and response to chromatin modifiers as a 
cellular chromosome. 
Transiently transfected plasmid DNA has been shown to be associated with nucleosomes of 
comparable stoichiometry but positioned randomly with intermediate nucleosomal assembly 
levels and fewer H1 molecules compared to stably integrated promoters. The decreasing level 
of H1 suggests that the nucleosomes become less stable as compared to a stable template 
(Hebbar and Archer, 2008). Nuclease digestion method in HEK293 cells confirmed that the 
transiently-transfected plasmid DNA is packed into histones to form an abnormal chromatin-
like structure (Mladenova et al., 2009). In addition, it was shown that the KRAB/TRIM28 
pathway is completely efficient within the context of episomal DNA (Barde et al., 2009).
Conclusion and outlook 
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7- Conclusion and outlook 
In this study, two members of the DUF3669-containing KRAB-ZNF subfamily have been 
investigated for their repressive activities in an attempt to unveil the role of their 
unconventional amino termini in their overall repression capacity. This study demonstrated 
transcriptional repression and the oligomerization properties of DUF3669. The amino 
terminal configuration of DUF3669-KRAB and the adjacent sequence constitutes an integral 
structural unit to exert sufficient repression activities even if the KRAB domain is a weak or 
non-functional repressor. The DUF3669 domain and the SUMOylation events add novel 
functionalities to their amino-terminal configuration. A TRIM28-independent residual 
repressor mechanism is considered to be partially involved as seen in HAP1 cells deleted of 
TRIM28. The insufficient repression activities of the tested KRAB domains are mainly due to 
their impaired binding to TRIM28 because of the absence of a conserved MLE motif in their 
KRAB-A subdomain. 
The conservation of some SUMO-receptor lysines in some DUF3669-containing zinc finger 
protein draws the attention to their importance in cellular physiology including transcriptional 
gene regulation which deserves further investigations. 
The underlying mechanism by which DUF3669 downregulates the reporter gene is unknown. 
Repression could occur directly e.g. by steric hindrance in this artificial reporter system of the 
RNA polymerase machinery, e.g. by recruitment of unknown factors to the promoter or by 
forming complexes with other DUF3669-containing KRAB-ZNFs or histone modifiers. 
Mutants of DUF3669 that fail to oligomerize are considered to be useful in the future to 
evaluate whether oligomerization properties are necessary for providing repression activities 
of DUF3669-containing KRAB-ZNF proteins.  
Identification of the endogenous target genes is a crucial step to unveil the biological function 
of individual KRAB-ZNF proteins. In addition, the use of such endogenous promoters gives 
more insight into the regulatory capacity of KRAB-ZNF proteins. For example, investigation 
of the transcriptional activities of ZNF746-derived fragment by using PGC-1α or TKT 
promotor can be more meaningful than an artificial luciferase system. 
Definitely, the HAP1 cell system has been proven to be an essential method to study gene 
modifications on the single gene level. 




8- Acronyms and Abbreviations 
APS Ammonium persulfate 
ATF7IP Activating Transcription Factor 7 Interacting Protein 
BR Bromodomain  
BSA Bovine Serum Albumin 
Co-IP Co-Immunoprecipitation 
DUF3669 Domain of Unknown Function 3669 
DTT Dithiothreitol 
FAM129A Family With Sequence Similarity 129 Member A 
GAPDH Glyceraldehyde-3-Phosphate Dehydrogenase 
GFP Green Fluorescent Protein 
GST Glutathione S Transferase 
H3K9me Methyl mark at lysine 9 of histone 3 amino-terminal tail  
HDAC Histone deacetylase 
HMTases Histone methyltransferase 
HP1 Heterochromatin protein 1 
HP1-BD Heterochromatin protein 1-binding domain 
KAP1 KRAB associated protein 1  
KOX Krüppel associated box  
KRAB Krüppel associated box 
MBP Maltose binding protein 
Ni-NTA Nickel-Nitrilotriacetic acid 
NuRD Nucleosome Remodeling Deacetylase 
PARIS Parkin Interacting Substrate 
PBS Phosphate Buffered Saline 
PGC-1α Peroxisome Proliferator-Activated Receptor gamma (PPARγ) 
coactivator-1a 
PHD Plant Homeodomain 
PINK1 PTEN-induced putative kinase 1 
PPARγ Peroxisome Proliferator-Activated Receptor gamma 
PTMs Post-transitional Modifications 
RBCC RING, B1box, B2box, and Coiled-Coil 
SAM S-adenosyl-L-methionine 
SCAN SRE-ZBP, Ctfin51, AW-1, and Number 18 
SDS Sodium Dodecyl Sulfate 
SDS-PAGE Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
SETDB1 SET Domain Bifurcated Histone Lysine Methyltransferase 1 
SIM SUMO Interacting Motif 
SUMO Small Ubiquitin-like Modifier 
TE Transposable Element 




TRIM28 Tripartite Motif Containing 28 
TRIS Tris(hydroxymethyl)aminomethane 
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S1: Protein equences of ZNF746 isoform a, ZNF746 isoform b, and ZNF777. 













EXON1- DUF3669(amino acids in bald are PF12417(EXON2)-KRAB-A(EXON3)-
KRAB-B(EXON4)-EXON5-EXON6-Zinc Finger Domain (highlighted motifs are 
Zinc fingers) (EXON7) 













EXON1- DUF3669(amino acids in bald are PF12417(EXON2)-KRAB-A(EXON3)-
KRAB-B(EXON4)-EXON5-EXON6-Zinc Finger Domain (highlighted motifs are 





















DUF3669(Amino acids in bald are PF12417) (EXON1)-KRAB-A (EXON2)-
KRAB-B (EXON 3)-Exon4-ZFs-containing region (highlighted motifs are 








S2: Zinc finger recognition code of human DUF3669-containing zinc finger proteins  
For each individual zinc finger, residues -1, 3 and 6 with respect to the start of the α-helix (that were 
proposed to be especially important for DNA-binding specificity) were extracted and consecutively 









-1,3,6 amino acids: 
>ZNF398_HS 
HRY-DRS-LSL-GAR-RHN-RHK-YTD 
                            1234567 
ZNF398HS_ZF_01  PTCPHCARTFTHPSRLTYHLRVH 
ZNF398HS_ZF_02  FPCPDCPKRFADQARLTSHRRAH 
ZNF398HS_ZF_03  FRCAQCGRSFSLKISLLLHQRGH 
ZNF398HS_ZF_04   SCPQCGIDFNGHSALIRHQMIH 
ZNF398HS_ZF_05  YPCTDCSKSFMRKEHLLNHRRLH 
ZNF398HS_ZF_06  FSCPHCGKSFIRKHHLMKHQRIH 




ZNF282HS_ZF_01  YSCPECGKSFGVRKSLIIHHRSH 
ZNF282HS_ZF_02  YECAECEKSFNCHSGLIRHQMTH 
ZNF282HS_ZF_03  YKCSECEKTYSRKEHLQNHQRLH 
ZNF282HS_ZF_04  FQCALCGKSFIRKQNLLKHQRIH 
ZNF282HS_ZF_05  YTCGECGKSFRYKESLKDHLRVH 
 
>ZNF212_HS 
YQT-HDR-QHQ      
ZNF212HS_ZF_01  YECSECEITFRYKQQLATHLRSH 
ZNF212HS_ZF_02  LICGYCGKSFSHPSDLVRHQRIH 




ZNF777HS_ZF_01  FTCMECGKSFRLKINLIIHQRNH 
ZNF777HS_ZF_02  YECAECEISFRHKQQLTLHQRIH 
ZNF777HS_ZF_03  YKCPECDSSFSHKSSLTKHQITH 
ZNF777HS_ZF_04  YTCPECKKSFRLHISLVIHQRVH 
ZNF777HS_ZF_05  FICSLCGKSFSRPSHLLRHQRTH 
ZNF777HS_ZF_06  FKCPECEKSFSEKSKLTNHCRVH 
ZNF777HS_ZF_07  HACPECGKSFIRKHHLLEHRRIH 
ZNF777HS_ZF_08  YHCAECGKRFTQKHHLLEHQRAH 




ZNF783HS_ZF_01  FPCPDCGQSFRLKINLTIHQRTH 
ZNF783HS_ZF_02  PACPYCGKAFRRPSDLFRHQRIH 




ZNF746HS_ZF_01  FTCATCGKSFQLQVSLSAHQRSC 
ZNF746HS_ZF_02  LRCGECGRCFTRPAHLIRHRMLH 
ZNF746HS_ZF_03  FPCTECEKRFTERSKLIDHYRTH 










S3: List of repression factors achieved by ZNF10 and GAL4 in HeLa cells used in Fig.15B, 15C, 15D 
and repression factors achieved by ZNF10 in HAP1 wildtype and knockout cells used in Fig. 17A, 17B, 
17C. 
HeLa HAP1-Wildtype TRIM28KO SETDB1KO 
Gal4 ZNF10AB ZNF10AB ZNF10AB ZNF10AB 
0,97366808 12,50520914 50,45913359 1,478939356 3,656835502 
1,02633192 13,09945775 45,00753292 1,437191973 3,296664887 
0,96934805 11,62159531 47,56336486 1,403518083 3,843987534 
1,03065195 14,32881065 46,6781602 1,357914386 3,69032766 
1,10912148 10,470916 40,28486762 1,566484636 3,674279257 
0,89087852 10,42398343 43,6563235 1,407605408 2,969034727 
1,0098002 21,26456711 36,33583383 1,329019285 3,706977365 
0,9901998 22,1467391 42,49818855 1,242886801 3,960148513 
1,01331501 18,93671614 29,60964175 1,008224623 3,752404825 
0,98668499 19,5204579 35,00268232 1,130681765 4,183090042 
0,98508653 10,26297016 25,86091198 1,059044327 3,928262396 
1,01491347 12,22212254 26,32035632 1,086609543 4,127453484 
1,01841572 16,18807922 31,91513024 2,004563839 4,921075901 
0,98158428 14,96601217 30,46001873 1,99393062 4,987182001 
1,0776672 15,6077092 27,20521046 1,83283882 3,893163155 
0,9223328 13,71760544 27,0455012 1,732456343 4,129676385 
0,96165551 18,57950018 33,32609557 1,493861902 4,136550046 
1,03834449 18,44051569 32,80160352 1,49940949 4,439783162 
0,9553938 10,98045607 21,18490541 1,18282444 5,650764199 
1,0446062 11,21397974 20,6841286 1,134214783 5,66300918 
1,04342659 12,72144182 16,19680341 1,702390109 4,877554107 
0,95657341 11,74156068 15,77813952 1,662287344 5,182000782 
1,10723202 15,3453358 38,477684 1,46085738 4,101300758 
0,89276798 15,30151655 36,25738881 1,19177303 4,768663935 
0,95762903 7,238729593 29,23969602 1,051731141 4,837995265 
1,04237097 6,922383943 25,66391791 1,194935126 4,977716808 
1,01171551 25,22110714 39,28697104 1,25410485 3,719907047 
0,98828449 27,05648653 45,01829826 1,178347509 3,960696313 
0,87462603 22,66681748 41,52768757 1,187254095 3,625022204 
1,12537397 21,70332869 40,95601601 1,40089945 4,372124336 
1,00656545 24,55139298 22,09838463 1,131931905 3,318306561 
0,99343455 21,10101902 20,29681716 1,177357748 3,453545482 
1,05037037 24,04568076 43,24086058 1,186830631 
 
0,94962963 22,95987061 41,14441158 1,267656263 
 
1,0042104 21,30135439 40,76443291 1,093512516 
 
0,9957896 24,98981635 40,12305434 1,147535178 
 
0,94701254 22,55963076 40,48324117 1,124774677 
 





















40 38 42 38 32 
Average 
1 16,95441034 34,69244709 1,33961716 4,181421994 
SD 
0,061327714 5,518666892 8,87533874 0,260468963 0,675726577 
unpaired two-tailed T-test  
ZNF10 vs GAL4 HAP1 wildtype vs 
TRIM28 ko 
TRIM28ko vs SETDB1ko 
 
9,493E-20 5,0263E-26 8,52894E-24 
  





















2,100006478 4,18975412 1,38474845 2,94150750 2,57850254 1,107183431 0,967865185 1,683788228 
1,911794348 3,80785741 1,35096665 2,7364057 3,22043387 0,81952296 1,02829344 1,50510219 
4,728283484 4,63197353 1,47739652 2,40339932 2,70408124 0,996753248 1,779295482 2,230220305 
3,674090738 4,07964799 1,42579461 2,33516077 2,96951539 1,046916862 1,885170547 2,474123064 
3,423215021 4,56529251 1,41362184 3,22430345 2,52859120 0,992911939 1,640693366 2,370686141 
3,939516304 4,16729932 1,40444861 2,75339911 2,30878616 1,060777419 1,51749689 2,385510311 
2,134253979 
     
1,626957983 1,492198234 
2,677473714 
     
1,691690602 1,532118913 
N 
8 6 6 6 6 6 8 8 
Average 
3,0736 4,2403 1,4095 2,7324 2,7183 1,0040 1,5172 1,9592 
SD 
1,02 0,31 0,04 0,33 0,33 0,10 0,34 0,44 









0,927131896 0,003435123 0,000469123 
 
S5: List of repression factors achieved by ZNF746b fragments in HeLa cells used in Fig.15C 
Z746b/1-294 Z746b/1-188 Z746b/109-294 Z746b/109-188 
12,2450472 4,985895063 5,461520518 3,054794033 
12,02701075 4,379831785 5,078700287 2,977315711 
13,76963434 5,715670565 9,818317823 3,240247619 
14,46929188 5,206681633 9,746710717 2,905634087 
10,65289426 5,67474417 9,456061966 3,128137536 












6 6 8 6 
Average 
12,5097 5,2266 8,0210 3,0529 
SD 
1,382533625 0,498866365 2,27605493 0,118225958 
unpaired two-tailed T-test of repression factors of tested evector plasmids against GAL4 alone 
5,22224E-06 4,6407E-06 5,21123E-05 5,36865E-08 
 
S6: List of repression factors achieved by ZNF777 fragments in HeLa cells used in Fig.15D 
Z777/1-831 Z777/1-362 Z777/1-282 Z777/189-254  Z777/283-362 
2,725625453 1,316557756 2,50703925 2,033601603 1,402093462 
2,821105671 1,092337521 2,60998511 2,062353052 1,514022989 
5,902834278 0,973358559 2,22350114 2,107847722 1,613482031 
5,783553427 1,012607804 1,75480319 1,983337124 1,583279111 
5,283019912 1,216146524 2,26481408 2,11057548 1,599818781 
5,504130765 1,222582295 2,04933742 1,813110739 1,602521947 
2,993613453 1,101349869 2,66063126 
 
1,332493982 




















8 12 12 6 12 
Average 
4,2480 1,1687 2,5390 2,0185 1,4679 
SD 
1,478670515 0,145464776 0,43696665 0,111385124 0,118174603 
unpaired two-tailed T-test of repression factors of tested evector plasmids against GAL4 alone 
0,000438964 0,001998875 8,9807E-08 1,55687E-06 7,79018E-09 
 
S7: List of repression factors achieved by ZNF746a fragments in HAP1 Wildtype cells used in Fig.17A 
HAP1 Wildtype 












3,217 8,819 2,361 4,639 1,795 1,059 2,405617962 
2,286 9,253 2,087 4,103 1,691 1,070 2,516815717 





3,323 6,964 2,335 4,788 1,633 1,030 2,508287577 
3,668 6,107 2,857 4,570 1,967 1,120 2,23599923 




























10 6 10 6 10 6 8 
Average 
3,93 7,23 2,62 4,60 1,97 1,03 2,80 
1,060153 1,465627093 0,349673721 0,270432801 0,381719175 0,075958498 0,696972706 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against TRIM28 KO 
0,477831 0,001278878 0,012502185 7,68607E-09 0,441149443 0,509680715 0,85887289 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against SETDB1 KO 
0,220344 0,000385263 9,55625E-07 5,2071E-07 0,000241891 0,243939532 0,001053836 
 
S8: List of repression factors achieved by ZNF746a fragments in HAP1 –TRIM28ko cells used in 
Fig.17A 
HAP1-TRIM28ko 










2,140917 5,22851807 1,573043041 2,328215696 1,603509731 1,029611985 1,740754369 
1,862196 5,34470525 1,61107775 2,52584088 1,661894119 0,983229237 1,813613617 
2,421793 3,124443719 1,496783047 2,167244467 1,372529359 1,031997709 3,526382529 
2,366033 3,010068445 1,551057551 2,535678056 1,36427399 0,969565574 4,139023202 
5,602894 2,905786972 2,60731011 1,969470625 2,428298174 1,008737411 2,986941136 
5,626056 3,061689723 2,418919441 1,88974283 2,302719168 0,989763058 3,088701285 
   
2,556909129 
   
   
2,230588088 
   
N 
6 6 6 8 6 6 6 
Average 
3,34 3,78 1,88 2,28 1,79 1,00 2,88 
SD 
1,775393 1,170407622 0,498183702 0,258714437 0,464114633 0,025540622 0,947941279 
unpaired two-tailed T-test of repression factors of tested construct in  TRIM28 KO against SETDB1 KO 







S9: List of repression factors achieved by ZNF746a fragments in HAP1 –SETDB1ko cells used in 
Fig.17A 
HAP1-SETDB1ko 










4,829447 2,410847118 1,477466295 1,855678411 1,222510288 0,961477388 1,431417948 
5,124717 2,404680499 1,351970008 1,912608062 1,139309824 1,088231372 1,543740103 
1,981404 2,350473142 1,425638674 1,932080757 1,273256381 0,98502512 1,546305805 
1,996832 2,363271852 1,537435725 1,890987667 1,352424593 0,925453839 1,511556813 
1,994105 2,064393759 1,595404393 1,998427397 1,352066141 0,984393727 1,421390664 
1,964666 2,076154748 1,417235207 2,122879841 1,38545575 0,902867031 1,455146165 
   
2,089536203 
   
   
2,022051125 
   
N 
6 6 6 8 6 6 6 
Average 
2,9819 2,2783 1,4675 1,9780 1,2875 0,9746 1,4849 
SD 
1,548351 0,16284258 0,088290387 0,096144731 0,094197866 0,064575308 0,056075785 
 
S10: List of repression factors achieved by ZNF746b fragments in HAP1 –Wildtype cells used in 
Fig.17B. 
HAP1-Wildtype 
Z746b/1-294 Z746b/1-188 Z746b/109-294 Z746b/109-188 
24,463 5,002 3,835 2,973 
24,467 5,081 3,881 3,085 
14,945 4,565 3,480 3,185 
12,982 5,042 3,427 3,020 
16,078 13,817 10,245 3,702 














6 10 10 6 
Average 
18,19 11,46 8,91 3,25 
SD 
4,995739825 6,328005801 5,380171995 0,303934596 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against TRIM28 KO 
0,000625484 0,000698578 0,001432716 3,04962E-06 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against SETDB1 KO 






S11: List of repression factors achieved by ZNF746b fragments in HAP1 –TRIM28ko cells used in 
Fig.17B 
HAP1-TRIM28ko 
Z746b/1-294 Z746b/1-188 Z746b/109-294 Z746b/109-188 
4,68260052 1,30036185 1,22159191 0,45764483 
4,78291593 1,32818494 1,246936 0,47996225 
2,61088643 1,16696447 0,90845322 0,47891294 
2,81015789 1,1695091 0,9443227 0,46582325 
2,83973427 1,65192982 1,50769023 0,44344997 
2,95912829 1,67124519 1,47178542 0,43965541 
N 
6 6 6 6 
Average 
3,447570555 1,381365895 1,21679658 0,460908108 
SD 
1,002279633 0,226925532 0,252937718 0,017195963 
unpaired two-tailed T-test of repression factors of tested construct in TRIM28 KO against SETDB1 KO 
0,030051347 0,843204721 0,236205995 1,46934E-05 
 
S12: List of repression factors achieved by ZNF746b fragments in HAP1 –SETDB1ko cells used in 
Fig.17B 
HAP1-SETDB1ko 
Z746b/1-294 Z746b/1-188 Z746b/109-294 Z746b/109-188 
2,17816671 1,37609171 3,40988972 0,74709723 
2,31387584 1,46274573 3,25785031 0,64448322 
2,28182742 1,29463642 1,07495617 0,78695764 
2,21092339 1,34322137 1,05655326 0,7619407 
2,11695834 1,40605412 1,1746402 0,78425047 
2,22321976 1,285522 1,15473781 0,73517808 
N 
6 6 6 6 
Average 
2,2208 1,3614 1,8548 0,7433 
SD 
0,070840022 0,067861771 1,147598613 0,052489132 
 
S13: List of repression factors achieved by ZNF777 fragments in HAP1 –Wildtype cells used in 
Fig.17C. 
HAP1-Wildtype 
Z777/1-831 Z777/1-362 Z777/1-282 Z777/189-254  Z777/283-362 
4,292 2,616 5,187 1,415 1,061 
3,958 2,735 5,636 1,696 1,034 
6,459 1,722 3,486 1,307 1,146 





5,683 1,371 3,495 1,461 1,211 
5,786 1,507 2,882 1,368 1,202 
6,483 
    
5,898 
    
8,620 
    
8,987 
    
N 
10 6 6 6 6 
Average 
6,26335 1,96580 4,06885 1,44124 1,14559 
SD 
1,598562017 0,575066732 1,086354077 0,134964166 0,08039312 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against TRIM28 KO 
0,020933551 0,084972165 0,006474081 0,043354969 0,004639678 
unpaired two-tailed T-test of repression factors of tested construct in Wildtype against SETDB1 KO 
0,000533537 0,02457104 0,00276001 0,001412723 7,29727E-06 
 
S14: List of repression factors achieved by ZNF777 fragments in HAP1 –TRIM28ko cells used in 
Fig.17C. 
HAP1-TRIM28ko 
Z777/1-831 Z777/1-362 Z777/1-282 Z777/189-254  Z777/283-362 
2,3340 1,5587 2,0747 1,2328 0,9952 
2,2659 1,6320 2,0508 1,1966 0,9728 
2,9531 1,4500 2,3180 1,3501 0,8730 
2,9053 1,6877 2,1788 1,3590 0,8010 
5,8630 1,2777 2,0730 1,3465 0,8362 








10 12 12 10 10 
Average 
3,78 2,32 2,60 2,25 1,79 
SD 
1,826463473 0,153649147 0,113309621 0,070063252 0,11508773 
unpaired two-tailed T-test of repression factors of tested construct in TRIM28 KO against SETDB1 KO 
0,503934494 0,002693851 1,37196E-06 0,007694671 0,022142931 
 
S15: List of repression factors achieved by ZNF777 fragments in HAP1 –SETDB1ko cells 
used in Fig.17C. 
HAP1-SETDB1 
Z777/1-831 Z777/1-362 Z777/1-282 Z777/189-254  Z777/283-362 
4,8063 1,2833 1,6760 1,0574 0,7395 
4,3748 1,3285 1,5109 1,0377 0,8890 





2,3950 1,2259 1,6819 1,1309 0,7841 
2,3280 1,1654 1,6399 1,1679 0,7948 








6 8 8 6 6 
Average 
3,1622 1,2224 1,6431 1,1375 0,7784 
SD 
1,136503908 0,080168478 0,055767311 0,086868051 0,062055537 
 
S16: List of repression factors achieved by ZNF10, KRAB domain of ZNF746b and mutants 








43,241 2,973 2,835 40,855 39,871 
41,144 3,084 2,865 42,572 40,906 
40,764 3,185 2,586 37,504 37,471 
40,123 3,020 2,677 36,149 39,176 
40,483 3,702 4,065 46,385 48,553 
41,733 3,560 4,485 42,423 48,276 
31,915 
    
30,460 
    
27,205 
    
27,046 
    
33,326 
    
32,802 
    
21,185 
    
20,684 
    
41,528 
    
40,956 
    
22,098 
    
20,297 
    
N 
18 6 6 6 6 
Average 
33,1662 3,2539 3,2522 40,9813 42,3755 
SD 
8,39582163 0,303948225 0,810048581 3,72206508 4,81026154 
unpaired two-tailed T-test of repression factors    
vs WT  109-188 
    0,996296001 1,7594E-06 5,5383E-06 





       0,58759067 
 
S17: List of repression factors achieved by ZNF10, KRAB domain of ZNF746b and mutants 








1,494 0,458 0,494 0,452 0,390 
1,499 0,480 0,390 0,449 0,452 
1,183 0,479 0,422 0,419 0,428 
1,134 0,466 0,420 0,401 0,422 
1,702 0,443 0,476 0,445 0,542 
1,662 0,440 0,477 0,473 0,570 
1,187 
    
1,268 
    
1,094 
    
1,148 
    
1,125 
    
1,109 
    
N 
12 6 6 6 6 
Average 
1,3004 0,4609 0,4465 0,4397 0,4674 
SD 
0,22535438 0,01719596 0,0415898 0,02560241 0,07218706 
unpaired two-tailed T-test of repression factors   
vs WT  109-188 
    0,4585975 0,12808083 0,83886963 
       GE vs RG/LE 
       0,40986848 
 
S18: List of repression factors achieved by ZNF10, KRAB domain of ZNF746b and mutants 
 in HAP1 –SETDB1ko  cells used in Fig. 20B 
SETDB1KO 






3,625 0,787 0,770 2,960 3,009 
4,372 0,762 0,735 3,151 2,972 
3,318 0,784 0,758 3,284 3,693 
3,454 0,735 0,745 3,314 3,236 
3,752 0,747 0,901 4,589 3,939 
4,183 0,644 0,886 4,452 3,824 
3,893 
    
4,130 






    
4,440 
    
5,651 
    
5,663 
    
N 
12 6 6 6 6 
Average 
4,2181 0,7433 0,7991 3,6250 3,4455 
SD 
0,75662048 0,05248913 0,07420585 0,70605679 0,42594089 
  unpaired two-tailed T-test of repression factors   
vs WT  109-188 
    0,16727129 0,00016299 1,6485E-05    
GE vs RG/LE    
0,60812323 
 
S19: List of repression factors achieved by ZNF10, ZNF10-DUF3669 chimera in HAP1-wildtype, 
HAP1-TRIM28ko and HAP1-SETDB1ko cells used in Fig. 21A. 












































































36,3358 33,8379 32,8450 1,4789 2,7177 1,4688 4,8776 4,3225 3,9139 
42,4982 35,9857 38,0455 1,4372 2,7294 1,4738 5,1820 3,9371 3,9431 
29,6096 31,9580 28,6842 1,4035 2,8425 1,6236 4,1013 4,1416 3,5864 
35,0027 30,8477 28,9311 1,3579 2,9286 1,6971 4,7687 3,4052 4,2003 
25,8609 27,1385 25,7084 1,5665 2,7532 1,4775 4,8380 4,1196 4,3554 
26,3204 24,6391 28,0109 1,4076 2,6698 1,4698 4,9777 3,8377 4,6752 
N 




30,73449 30,37084 1,44194 2,77352 1,53508 4,79087 3,96062 4,11238 
SD 
6,50376 4,214269 4,410159 0,07296 0,09492 0,0998 0,36705 0,3203676 0,3816353 
    unpaired two-tailed T-test of repression factors "with DUF" vs "without DUF" 
  0,5697198 0,5042210   3,0075E-
10 
0,09750518   0,00198126 0,01055199 
 
S20: List of repression factors achieved by the amino half wildtype of ZNF746a and the SUMO-
receptor lysine mutant in HeLa and HAP1 cells used in Fig. 21A. 
HeLa HAP1-Wildtype 
Z746a/1-279 Z746a/1-279K189R Z746a/1-279 Z746a/1-279K189R 
4,189754125 1,243734892 8,81861139 0,849927679 





4,631973538 1,371008119 6,50572295 0,674472076 
4,079647999 1,433332102 6,96357528 0,63169645 
4,565292519 1,296789279 6,10672447 0,867370571 







6 8 6 6 
Average 
4,2403 1,3049 7,2288 0,8025 
SD 
0,309750846 0,180519663 1,46562709 0,117925769 
unpaired two-tailed T-test of repression factors mutant vs wildtype 
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